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1.  Introduction  
1.1  Host-microbiota interaction in the gut 
A tremendously complex and dynamic union of microorganisms inhabits the mammalian 
gastrointestinal tract and contributes to several aspects of host physiology including 
metabolism, maturation of the immune system, cellular homeostasis and behavior1,2,3. 
This diverse microbial community is composed of bacteria primarily, but also includes 
archaea, viruses, fungi and protozoa2. In a lately publication from Ron Sender and 
colleague, the number of microbes cells in colon is “only” 1.3 fold than human cell 
(3.8×1013 microbes cells in colon and 3.0×1013 human cells) with a wide uncertainty in a 
“reference man” (age: 20–30, weight: 70 kg, height: 170 cm)4. Furthermore, the genes of 
microbes that make up the microbiome in the whole body outnumber human genes at 
least two orders of magnitude, especially with over 3 million bacterial genes in the gut5. 
There are several benefits of gut microbiota to the host, including protection against 
enteropathogens6, extracting nutrients and energy from our diets7 and maintain the normal 
immune function8. However, the commensal microbial communities within the host also 
represent a potential danger due to their infection and overgrowth.  
The dysbiosis in the gut might lead to obesity9, malnutrition10, inflammatory bowel disease 
(IBD)11, neurological disorders12 and even colon cancer13. The loss of microbiota diversity 
has been shown associated with several diseases (Figure 1). By this observation, loss of 
microbiota diversity is generally considered as the consequence of the disease instead of 
the cause. However, some recent studies suggested different concepts of the role of 
microbiota in gut inflammation. Michail et al found the increase of diversity in pediatric 
patients with ulcerative colitis (UC) who responded to corticosteroids than the non-
responder paitents14. Additionally, Crohn’s disease (CD) can also be triggered by a 
dysbiotic gut microbiota in a mouse model15. Altogether, these results provide the strong 
argument for a causal effect of change of diversity in several human conditions16. 
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Figure 1 Associative links between Western lifestyle, Human conditions, and loss of 
microbial diversity  
Most of the human diseases affecting westernized countries are associated with microbiota 
diversity on the right side of figure. However, some western lifestyle patterns cause the loss of 
microbiota diversity in the left side of figure. Microbiota diversity appears to play a prominent 
role to link western lifestyle and western chronic human conditions 
Figure is from Mosca et al16  
 
Intestinal epithelial cells (IECs) play a central role as they line the gastrointestinal mucosa 
and built a physicochemical and immunological barrier to restrain the microbiota and 
prevent invasion17,18. Interactions between the microbiota and the host, especially IECs, 
have therefore been studied intensively in the past decade19. Previous studies have 
shown that under normal homeostatic conditions, the gut microbiota regulates the 
expression of about 10% of host genes19. NOD2 (Nucleotide-binding oligomerization 
domain-containing protein 2), a prototypic NLR gene, identified as a risk factor for Crohn’s 
disease20, was shown to specifically react to the intracellular presence of the bacterial cell 
wall component muramyl dipeptide18. Several mechanisms have been implicated in how 
the gut microbiota can drive these global changes in the host transcriptome. 
Transcriptional regulators such as NFκB (nuclear factor kappa-light-chain-enhancer of 
activated B cells) or CEBPB (CCAAT/enhancer-binding protein beta) may be engaged by 
the microbiota to modulate the expression of specific target genes21. 
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1.2  Role of intestinal epithelium 
The intestinal epithelium, composed of single layer of cells, builds a physical barrier to 
separate the external environment and host tissues of the gastrointestinal tract22. This 
single-cell layer consists of four major cell lineages including absorptive enterocytes, 
goblet cells, enteroendocrine cells and Paneth cells (Figure 2). The majority in IECs are 
absorptive enterocytes, which serve for nutrient absorption. They express many catabolic 
enzymes on their exterior luminal surface to break down proteins and sugars from the gut 
into smaller particles that are more easily absorbed. The function of goblet cells is to 
secrete the mucus layer that protects the epithelium from the luminal contents. 
Enteroendocrine cells are specialized hormone-producing endocrine cells in the 
gastrointestinal tract and Paneth cells are the main producers of antimicrobial peptides23.  
An intestinal stem cell (ISC) can be defined by two properties: self-renewal and 
multipotency24. ISC can maintain itself throughout long periods and differentiate into 
enterocytes, goblet cells, enteroendocrine cells and Paneth cells. During cell 
differentiation, enterocytes, goblet cells and enteroendocrine cells will migrate upward to 
the top of the villi where cellular apoptosis and epithelial shedding occur and Paneth cells 
will migrate downward to the bottoms of the crypts.  
These various functions of subsets of IECs maintain intestinal homeostasis by separating 
the intestinal lumen from the underlying lamina propria and persevere symbiotic 
relationship with the host and intestinal bacteria. The colonic microbiota breaks down 
complex carbohydrates that cannot be metabolized by the host; bacterial fermentation 
generates short-chain fatty acids (SCFA) that serve as energy sources for colonic 
epithelial cells; colonic bacteria produce antimicrobial peptides that promote the 
maintenance of a symbiotic community23. Incompleteness of intestinal epithelium is a key 
pathogen of IBD25. Detrimental microbial composition changes will induce an 
inappropriate immune response causing damage to the intestinal epithelium.  
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Figure 2 Intestinal epithelial cell lineages and the formation of the crypt-villus axis.  
The intestinal epithelium consists of four major cell lineages that arise from a pluripotent stem 
cell progenitor located in the epithelial crypt region including absorptive enterocytes, goblet 
cells, enteroendocrine cells, and Paneth cells. The figure is modified from Yu et al.26  
 
 
1.3  Intestinal inflammation and inflammatory bowel 
disease 
The human digestive system is composed of the gastrointestinal tract plus the accessory 
organs of digestion that includes mouth, esophagus, stomach, small intestine, and large 
intestine. Gastrointestinal tract controls entire host metabolism and physiology and 
constitutes/represents the most diverse ecosystem of microbial interactions. Inflammation 
anywhere in the gut disrupts this normal process. The term IBD describes chronic 
inflammation of the intestine, which may affect different parts of the gut. IBD comprises 
two distinct subforms: UC and CD. The primary difference from UC and CD is the 
inflammation location where the digestive tract is affected. CD usually occurs in patches 
with granuloma formation and may affect any part of the gastrointestinal tract from mouth 
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to anus, though it primarily affects terminal ileum and colon. The areas of severe, 
persistent and transmural inflammation develop thickened sub-mucosal wall, strictures, 
fistulae, fissures, abscesses and fat deposits. However, UC shows that continuous 
inflammation is mainly limited to mucosa and submucosa of the colon and rectum which 
develop sores or severe ulceration27 (Figure 3). The main symptoms of IBD are diarrhea, 
bleeding ulcers, stomach pain, weight loss and anemia. People with CD may get canker 
sores in their mouths, and the inflammation may also affect the skin, eyes, joints, and liver. 
In general, UC and CD have similar symptoms; hence, it is difficult to distinguish these 
two subtypes in the initial stage. 
 
Figure 3 Comparison of CD and UC effects position    
The red patches show active inflammation in intestines, and the white patched shows the normal 
part of the intestine. The figure is modified from Save Jon Blog: PSC and IBD: What’s the 
Connection? (http://blog.save-jon.org/blog/psc-and-ibd-whats-the-connection) 
 
Over the past decades, the prevalence of IBD increased significantly, especially in the 
developed countries28. In the United States, approximately 1-2 million people have IBD, 
with an incidence of 70-150 cases per 100,000 individuals28. CD  and  UC  prevalence 
rate in European countries is around 322 and 505 per 100,000 individuals respectively29. 
Moreover, according to a survey from Hein and colleagues30 in a large insurance cohort, 
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the IBD prevalence in Germany considerable increase since the 1980s. The IBD 
prevalence in 2010 was 744 per 100,000 (CD: 322, UC: 412 per 100,000 persons). These 
high incidence rates in Europe/Germany suggested that the lifestyle of western industrial 
societies is a contributing factor to an increased pathogenesis of IBD. The disease onset 
for CD and UC can happen at any age across pediatric and adult populations,  while the 
rates are usually reported to be bimodal: the first peak is in the age group of 15-30 years 
and the second occurs in the aged group 50-7031.  
The exact cause of IBD remains unknown. However, genetics and gut microbiota have 
been associated with IBD. Genetic has been reported as an essential component long 
before for IBD, especially in CD32,27. This genetic effect can be seen from various familial 
aggregations, sporadic and twin studies33. Accordingly, the first-degree relatives IBD 
patients have risk 3 to 20-fold greater likelihood of developing the disease than the general 
population34 and the likelihood increases further if both parents suffered from the 
disease35. International IBD Genetics Consortium (IIBDGC) recently identified totally 201 
known IBD risk loci based on 75000 IBD (UC and CD) patients and healthy controls. 
Together, these loci explain 13.1% and 8.2% of the variance in disease liability in CD and 
UC respectively36. Most of the genes within the identified loci were also associated with 
key pathways involving both innate and adaptive immune system that are disturbed 
around IBD patients. Therefore, many IBD patients shared with other complex immune-
mediated diseases like celiac disease, psoriasis or rheumatoid arthritis. However, genetic 
effect is not the dominant risk factor, considering the result of twin studies; CD shows a 
concordance of 20-50% in monozygotic (identical) twins and only 10% in dizygotic twins. 
The concordance would have been close to 100% in monozygotic twins and around 50% 
in dizygotic twins if the genetic components were fully responsible for IBD.  
The aetiopathogenesis of inflammatory bowel disease has been considered from the host 
perspective for a long time, but more and more studies reveal the significant influence of 
host-gut microbiota interaction on IBD. Gut microbiota dysbiosis with a breakdown of host-
microbial mutualism is probably the marking event in the development of IBD37. The 
reduced abundance of the phylum Firmicutes has been noticed in patients with IBD11. on 
the contrary, several studies reported the increased number of phylum Bacteroidetes in 
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the IBD patients38. These two dominated phyla make up for 90% of the phylogenetic 
categories in the normal gut microbiome ecosystem, and it is interesting to see the 
disparate ways where they are altered in IBD. Probiotics and prebiotics treatment have 
been applied in IBD therapy, this therapeutic strategy aims to restore the balance of the 
gastrointestinal microflora in order to reduce or prevent intestinal inflammation39. As 
microbiota are involved in IBD, fecal microbiota transplantation has been considered as a 
possible treatment for rebooting the gut microbiota composition in IBD patients. However, 
the evidence are insufficient to recommend fecal transplantation in IBD. This approach 
needs to be constructed the optimal design of delivery as well as randomized, placebo 
controlled trials to establish the effectiveness of fecal transplantation40. 
 
1.4  Transcriptome studies in intestinal inflammation  
The transcriptome studies in intestinal inflammation provide us the evidence which 
describes the role of protein-coding and non-coding RNAs in modulating immune 
responses in IBD. Recently, more and more IBD-related genome-wide expression studies 
came out because of the NGS technique. That provides us a broad view of various study 
topics including site-specific comparison, IBD patient and healthy comparison, healthy 
tissue and inflamed tissue in IBD patients comparison, gene expression change in 
different developmental stages...etc. The understanding of transcriptome can help the 
clinical research for identifying the disease-associated gene that might serve as targets 
for therapeutic intervention. Furthermore, the targeted genes with the difference in 
transcription level can serve as the biomarkers to distinguish the subtype of IBD41 or the 
period of the disease42.  
The transcriptome analysis for IBD started earliest in 1997 by using spotted cDNA arrays43. 
This study only compared 1000 pre-selected genes between tissue samples of 
rheumatoid arthritis and IBD due to the technology limitation. Nevertheless, still some 
genes were identified as differentially expressed genes with the function of tissue inhibitor 
of metalloproteinase, ferritin light chain, and manganese superoxide dismutase. 
Dieckgraefe and colleagues44 next examined colonic mucosa samples using Affymetrix 
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Hum 6000 arrays with a coverage of ∼6500 genes and expressed sequence tags. This 
study identified 74 differentially expressed genes between inflamed UC and normal 
mucosa, grouping in functional classes such as immunoregulation and tissue regeneration. 
For the diagnosis purpose, it is difficult to distinguish UC and CD precisely by gene 
expression pattern. Because inflamed mucosa from UC and CD are remarkably similar45. 
Although the similarity of transcriptome pattern in inflamed mucosa from UC and CD might 
not help for diagnosis, Olsen et al. used random forest modeling of genome-wide gene 
expression data for distinguishing quiescent and active UC colonic mucosa versus control 
and CD colonic mucosa46. Many following studies also discovered the list of significant 
genes in the different scenarios; however, the results are highly inconsistent even in the 
similar experimental setting. 
There are two major reasons for the inconsistency: material resource and sample size 
(statistical power). Sample heterogeneity greatly changes the expression levels. Paneth 
cell metaplasia, leukocyte infiltration, crypt hyperplasia and ulceration with loss of 
epithelial cells are essential factors for gene expression levels47. Different cell types, 
different sample locations and even sequencing runs might end up to different results.This 
diversity often hinders the interpretation of the differences between sample groups. 
Moreover, the small sample size in each study increases the uncertainty and lower the 
reliability of the finding. With the small sample sizes (n<20), one need to very cautious for 
the false positive. Thus, validation process becomes a crucial step in IBD transcriptome 
study. One can either validate the finding in the independent cohort with different 
technique or benchmark with the former similar study. In addition, the meta-analysis, 
which merges the dataset from different studies, might be another alternative. Granlund 
et al.45 employed the meta-analysis approach, by showing a similarity between the gene 
expressions in inflamed mucosa from UC and CD patients and furthermore confirmed by 
hierarchical clustering of 10 external data set from published article. 
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1.5  DNA methylation in inflammatory bowel disease 
Many observations in humans family study and animal models all suggest that genetically 
determined factors contribute to IBD susceptibility48. Even though, genetics factor can only 
explain a small proportion of disease heritability (CD: 13.1% and UC: 8.2% of disease 
variance)36. To unravel other parameters which might be less strong than genetic effect 
become the further direction of IBD research. One of such newly created fields is 
epigenetics, particularly in DNA methylation. Epigenetic mechanism includes three major 
components: DNA methylation, histone modification, and non-coding RNA. DNA 
methylation is thought to inhibit gene transcription, but recent data indicates that the 
functional consequences may be more complex49. DNA methyltransferases (DNMTs) 
family enzymes catalyze DNA methylation. Methyl groups can be reprogramed via actions 
of DNA demethylases such as intestinal maturation process or disease onset of IBD. In 
the following content, the roles of DNA methylation will be discussed in the context of the 
IBD-related epigenome study. 
 
1.5.1  DNA methyltransferases and IBD 
There are three DNA methyltransferases, which have been proposed in the pathogenesis 
of IBD and IBD associated colorectal cancer (IBD-CRC): DNMT1, DNMT3A, and 
DNMT3B (Figure 4). DNMT1 is a key maintenance methyltransferase that primarily 
methylates hemimethylated DNA in the genome during DNA replication50. DNMT1 is 
highly expressed in active inflamed UC colon mucosa than in normal or quiescent UC 
colon mucosa51.  DNMT1 expression induces not only an elevation of genomic DNA 
cytosine methylation, but also CpG island methylation in promoter regions in particular 
targeted genes52. Signal transducer and activator of transcription 3 (STAT3) bind directly 
onto the DNMT1 promoter in malignant T cell lymphoma that might induce DNMT1 
expression53. DNMT3A/B and DNMT1 regulate DNA methylation maintenance 
cooperatively. Besides, DNMT3A/B have additional roles in de novo DNA methylation and 
demethylation functions. DNMT3A involves in innate and adaptive immune responses. It 
suppresses interferon gamma (IFNγ) transcription in T cells by directly inhibiting 
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transcription factor binding54. DNA methylation in interferon gamma gene (IFNG) promoter 
region is correlated with IFNG expression and immune response against microbial 
antigens in UC patients55. DNMT3B expression showed upregulated in active UC colonic 
mucosa compared to normal colonic samples but relatively lower than that of DNMT151 
(Figure 4). Huidobro et al. found the hypermethylation pattern on the distal DNMT3B 
promoter in human colorectal cancer cell lines (HCT15, DLD1, Col15, HT29, SW480 and 
RKO). On the other hand, low expression of DNMT3B results in hypomethylation of 
FURIN gene promoters56. Furthermore, DNMT3 has been reported in GWAS study as a 
CD associated risk loci57. To summarize, the different expression level in DNMTs might 
serve as a biomarker for subtype diagnosis or monitor IBD and IBD-CRC progression in 
patients. 
 
 
Figure 4 Potential relative expression levels of DNMTs in different IBD associated disease  
The relative DNMTs expressions were normalized to healthy controls to display potential 
relative expression in different inflammatory bowel disease associated diseases: active-UC, 
inactive-UC, IBD-CRC and sporadic-colorectal cancer patient specimens consolidate from 
several studies. Figure is from Low D et al, 201350 
 
1.5.2  Whole methylome profile in IBD study  
Microarray technique, especially Illumina infinium human 27k & 450K, has been widely 
employed to investigate the genome-wide epigenetic variants58,59. Moreover, the recent 
next generation sequencing60,61 provides the comprehensive view for  DNA methylome 
studies in different tissue/cell. One can apply these high-throughput data to connect 
between common diseases and complex traits or integrate methylome data with the 
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different layer of omics data (e.g. transcriptome, microbiome). Epigenome-wide 
association studies (EWAS) which connect epigenetic variant and disease has been 
applied in various clinical research fields, such as cancer, type 2 diabetes, obesity and 
other complex diseases. It aims to detect the variants that associated with the complex 
phenotype and determine the novel gene and the pathway in common disease. DNA 
methylation in the promoter region is thought to be associated with gene expression. 
However, the integration studies of methylome and transcriptome discovered the 
methylation modification for gene expression also in gene body, transcription start sites 
and enhancer region62.  
Nimmo et al59 compared the methylation level from 21 ileal CD patients and 19 healthy 
controls in whole blood genomic,1174 CpG sites were identified as differentially 
methylated. Out of these CpG sites, 35 genes were found overlapped with published 
GWAS study in CD, including NOD2, TNFα and CARD9 (caspase recruitment domain 
family, member 9). Häsler et al49 examined three layers of genome-wide scans in 20 
monozygotic twins discordant for UC, including transcriptome profiling, genome-wide 
differentially methylation positions (DMPs) and genome-wide differentially methylation 
regions (DMRs). They revealed 61 diseases associated gene with at least one DMP or 
DMR in the 50kb windows from the transcription starting sites. However, none of them 
overlapped with the identified UC GWAS loci63. Cooke et al58 established multiple 
comparisons between inflamed/non-inflamed UC and CD. Interestingly, the methylation 
profile between inflamed UC and inflamed CD showed no difference, but the difference 
was found in 13 positions in non-inflamed UC and non-inflamed CD. That might imply the 
subtype of IBD can be distinguished by their methylome status. Additionally, the age-
dependent methylation dynamics needs to be considered as an important risk factor in 
IBD64. One mouse study showed that 271 methylation loci underwent significant alteration 
during this developmental period in dextran sulfate sodium colitis model64. In conclusion, 
whole methylome screening will become a useful clinical diagnostic tool to detect the 
biomarker in IBD.  
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1.6  Epigenetic markers and host-microbiota interaction 
The microbiota has the potential to modulate host epigenetic mechanisms and thereby 
regulate transcription more globally65,66,67. The microbially produced short-chain fatty 
acids (SCFAs) butyrate and propionate are potent inhibitors of histone deacetylase 
(HDAC) enzymes68 and therefore may promote heterochromatin formation and increase 
transcriptional activity. However, global changes in the accessible chromatin landscape 
by the gut microbiota were not detected in previous study21. Additionally, the intestinal 
microbiota may modulate DNA methylation, since microbially produced folate is an 
essential methyl donor during DNA methylation67.  
Yu and colleagues have shown that during postnatal development, both the epithelial 
transcriptome and the DNA methylation landscape underwent fundamental reshaping69. 
The early neonatal period is a critical phase not only for the development of the intestinal 
tract but also for the establishment of the microbiota and proper maturation of the immune 
system70,71. Notably, colonization at a later stage fails to normalize these immunological 
defects. This persistence of microbiota-dependent regulatory signatures points to 
microbial imprinting through epigenetic mechanisms (possibly DNA methylation) that are 
long lasting once they are established2,72. However, whether microbial colonization early 
in life alters the DNA methylation pattern and alongside the epithelial transcriptome during 
postnatal development and maturation of the gut epithelium remains largely unknown. 
 
1.7  Technological consideration on next generation 
sequencing 
Discovering the full DNA structure and its role to answer the complex biological questions 
has been the dream of mankind since a longtime. The “original” DNA sequencing 
methodology, known as Sanger chemistry, uses specifically labeled nucleotides to read 
through a DNA template during DNA synthesis73.  After a series of technical innovations, 
the Sanger method has reached the capacity74. In order to sequence longer sections of 
DNA, a new approach called shotgun sequencing was developed during the 
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establishment of Human Genome Project (HGP)75. Shotgun sequencing divides human 
chromosomes into DNA segments of an appropriate size and then subdivides these 
segments into smaller, overlapping DNA fragments for sequencing. Next step after 
sequencing is to fill in gaps and resolve DNA sequences in ambiguous areas which are 
not obtained during the shotgun phase76. The core philosophy of massive parallel 
sequencing used in next-generation sequencing (NGS) is adapted from shotgun 
sequencing77. It allowed the mass parallelization of sequencing reactions, greatly 
increasing the amount of DNA that can be sequenced in one run. This massively parallel 
sequencing technique revolutionized sequencing capabilities from the first sequencing 
techniques leading to the coining of the term “next-generation sequencing”.  
Pyrosequencing method was the first sequencing technology established by 454 Life 
Sciences which was followed by Illumina/Solexa technology in 2007, SOLiD (Sequencing 
by Oligo Ligation Detection) by Life Technologies, and PGM (Personal Genome Machine) 
by Ion Torrent in 2010. 454 Life Sciences was purchased by Roche in 2007 and shut down 
in 2013 when its technology became noncompetitive78; likewise, Ion Torrent was bought 
by Life Technologies at the end of 201279. Nowadays, Illumina occupies around 70% of 
the sequencing market. Apart of general sequencing method, Oxford Nanopore 
developed nanopore sequencing since 2008. The advantages of Oxford Nanopore are 
minimal sample preparation, sequence readout that does not require nucleotides, 
polymerases or ligases, and the potential of very long read lengths (>10,000-50,000 nt)80. 
Nanopore sequencing approach has long been a potentially strong competitor in 
sequencing market, but the company struggled to deliver a real-world commercial device. 
The basic workflow of NGS involves library preparation, cluster generation and 
sequencing; though library preparation might differ in different technologies. The 
generated data processing is followed by bioinformatics analyses of the sequencing data 
(2.2 Analytical pipelines ).  
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1.7.1  16S rRNA sequencing  
“What is the microbial composition there?” is one of the most frequent questions in 
microbial ecology. This question can be answered using various tools, but one of the long-
lasting gold standards is to sequence 16S ribosomal RNA (16S rRNA) gene amplicons81. 
16S rRNA sequence analysis, a culture-independent method, has been widely used to 
clarify the taxonomic affinities of bacterial taxa and as a powerful tool for assessing the 
diversity of environmental or clinical samples82. The 16S rRNA gene is a section of the 
prokaryotic DNA present in all bacteria and archaea. In contrast to the genes needed to 
make enzymes, mutations in 16S rRNA can be less tolerated since it may affect structures 
essentially (if a bacterium does not have the gene to make the enzymes needed to utilize 
lactose, it can use an alternative sugar or protein as an energy source). Thus, few other 
genes are as highly conserved as the 16S rRNA gene83. The consistency of these short 
regions (1542 nucleotides) increases its detection specificity and also the length allows 
us for the universal primer.  
The 16S rRNA gene can be subdivided into highly conserved primer binding sites and 
nine variable regions (V1-V9 in Figure 5). The variable regions depict species-specific 
signatures. Universal primers are usually chosen as complementary to the conserved 
regions at the beginning of the gene and at either the 540-bp region or at the end of the 
whole sequence and the sequence of the variable region in between is used for the 
comparative taxonomy83. The 16S rRNA gene can directly be isolated by PCR with 
universal primers targeting the conserved regions. The library preparation is followed from 
the protocol of Illumina MiSeq 16S Metagenomic Sequencing Library Preparation84. Here , 
in this study, V3 and V4 region were amplified, both Illumina sequencing adapters and 
dual‐index barcodes were added to the amplicon target. Paired 300‐bp reads sequencing 
and MiSeq v3 reagents were employed. The ends of each read were overlapped to 
generate high‐quality, full‐length reads of the V3 and V4 region84. The data preprocessing 
detail are described in 2.2.1  
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Figure 5 16S rRNA secondary structure for the Toll sequence.  
Regions V1 to V9 are hypervariable regions as determined by Ashelford et al85.; approximate 
nucleotide positions are given in parentheses. Numbering is unique to this structure. Modified 
from Justine R. Hall et al 86 
 
 
1.7.2  RNA-Seq 
Genetic information from DNA to proteins is passed down via mRNA in a finely regulated 
fashion, wherein identity of each expressed transcript and its transcriptional levels make 
up the “transcriptome87.” The definition of transcriptome can be stated as the complete 
set of messenger RNA (mRNA), which is produced by the genome in a single cell or a 
population of cells. Recently, RNA-Seq has been widely used for transcriptome profiling 
by deep-sequencing technologies which have several advantages over other existing 
approaches, especially low background noise and high reproducibility88. It provides a 
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precise measurement of gene expression levels from all transcripts and their isoforms89. 
It can detect even subtle changes in gene expression in response to environmental 
changes which are not captured by other methods. A typically established RNA-Seq 
workflow (Figure 6) starts with total RNA sample isolation and preparation, then followed 
by a ribosomal depletion step during purification to exclude ribosomal contamination. RNA 
is highly sensitive and easily degraded by RNAse enzymes; therefore, extreme care 
should be used while handling RNA samples.  
 
 
Figure 6 Principle sequential steps of an RNA-Seq workflow  
 
 
1.7.3  RRBS 
RRBS (reduced representation bisulfite sequencing) was first mentioned by Meissner et 
al.90. It is a restriction enzyme based (MspI, 5’-C|CGG-3’) CpG enrichment method for 
DNA methylation analysis (Figure 7A). Bisulfite treatment converts unmethylated cytosine 
residues into uracil while methylated cytosines remain unchanged. The restriction enzyme 
(here is MspI) selects a size-range fragment for sequencing. This technique combines 
both bisulfite sequencing and restriction enzymes because MspI specifically recognizes 
CCGG sequence (Figure 7B). The reads are enriched with the high CpG content areas of 
the genome. Though RRBS captures only 1% of the whole genome, it can generate 
accurate methylation levels for most CpG rich and regulatory regions from sample input 
as low as 10ng91 well suited for many clinical samples like tumors, sperm cell etc. These 
regions are typically CG islands or promoter regions92, therefore, RRBS is a great way to 
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get high coverage methylation data on promoters. On the other hand, the detected sites 
might not be really representative. People need to be cautious about the conclusions of 
distal regions drawn simply based on RRBS. In my mouse study, I looked at a ‘reduced 
and low-complexity’ fraction of the genome at single nucleotide level. The other caution 
while using RRBS is the conversion efficiency of BS. In order to determine conversion 
efficiency prior to sequencing, lambda DNA were added in as an internal control (spike-
in). The quality of conversion rates is based on the methylation status at non-CpG sites93. 
The biggest advantage of RRBS compared to WGBS (whole genome bisulfite 
sequencing), is cost-effectiveness since it focuses on the enrichment of CpG-rich regions 
in close proximity to the restriction enzyme’s recognition sequence; however, these may 
exhibit a lack of coverage at intergenic and distal regulatory elements that are relatively 
understudied94.  
  
 
Figure 7 Principle and workflow for RRBS 
(A) RRBS working flow; (B) Target cutting site of the MspI enzyme so that every read starts 
with either CGG or TGG depending upon the genomic state and will have information for at 
least one CpG dinucleotide. Figure is modified from: RRBS guide, Babraham95  
 
1.8  Aims of this thesis 
The change of host physical conditions might reshape the host-microbiota balance in the 
context of transcription and epigenetic. Although, the interactions between the microbiota 
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and the host are well established in previous studies, the cross talk between host 
epigenetic marker, transcription and gut microbiota in whole genome scale remains 
largely unknown. The aim of my thesis is to build a genome-wide map of the epigenetic 
marks (DNA methylation) with the different intestine conditions, and furthermore 
investigate host-microbe association in the murine gut. I expect the finding can provide a 
clear picture of the role of gut microbiota together with the epigenetic change in intestine 
inflammation. 
 
 Hypothesis 
I hypothesize that epigenetic marks (i.e. DNA methylation) are important biological 
master switches that contribute to the stability of the physiological host-flora 
association. In order to validate my hypothesis, I investigated the interplay of 
epigenetic marks, transcriptomal signatures and microbial communities in mice and in 
a human cohort of UC twins.  
 
 Aims 
 The aim of the first study is to build a genome-wide map to present UC 
relevant effects on three layers: transcriptome, epigenome and gut 
microbiota.  
 In the second study, I furthermore sought to investigate the microbial effects 
on DNA methylation and the transcriptome of intestinal epithelial cells (IECs) 
during postnatal development. 
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2.  Material and Methods 
This section will provide the insights into sample preparation and various data analysis 
procedures including Methylation27K microarray, Affymetrix gene expression microarray, 
16S rRNA gene sequencing, RRBS and RNA-Seq. Data analysis mostly includes in-
house pipeline established for whole genomic screening. 
 
2.1  Sample preparation  
2.1.1  Twins study 
There are two panels in this study: screening panel and validation panel. Screening panel 
consists of twenty monozygotic twins, discordant for ulcerative colitis (median age: 25, 
range 18-70). Biopsies were taken endoscopically from a defined area of the colon and 
immediately snap-frozen in liquid nitrogen. All biopsies used in this screening panel were 
primary tissues from the intestinal mucosa. DNA and RNA were extracted from sampled 
biopsies. DNA was extracted from biopsies using the QIAamp Tissue DNA preparation kit 
(Qiagen). Total RNA was extracted and processed by RNeasy mini-kit from Qiagen and 
quality controlled using an Agilent Bioanalyzer according to the manufacturer’s protocol. 
These data were already published by Haesler and colleagues49 in 2013.   
Forty unrelated UC patients (n=20) and healthy control individuals (n=20) were recruited 
in the validation panel. The criteria for healthy participant includes age between 18 and 
50, no antibiotic or antimycotic treatment in the previous 6 months, no probiotic based 
product consumption, hospitalization, and/or diarrhea in the previous 6 months, no known 
infection and sign of inflammatory markers. The biopsies in this cohort were sampled from 
the sigmoid colon. UC patients were selected for displaying an endoscopically active 
disease in the sigmoid colon at the time of sampling. The bioethical committee of the 
University of Kiel, where the patients were recruited, approved the study setup. DNA and 
RNA was extracted using same procedures as for screening cohorts. Validation of the 
observation was performed using real time PCR of transcript levels and microbiota as well 
as amplicon sequencing of DNA methylation.   
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2.1.2  Mouse study  
C57BL6/N female littermate mice were maintained under standard specific pathogen free 
or GF conditions in the laboratory for experimental biomedicine at University of 
Gothenburg as described in the publication of Sommer et al 201519. Mice were kept under 
a 12-h light cycle and fed autoclaved chow diet ad libitum (Labdiet, St Louis, MO, USA). 
They were sacrificed at different stages: week 1, week 4 and between week 12 and 
week16. Mice were killed by cervical dislocation and the small intestines were removed 
for isolation of IECs. All animal protocols were approved by the Gothenburg Animal Ethics 
Committee. IECs were isolated from small intestinal tissue using the Lamina Propria 
Dissociation Kit (Miltenyi BioTech, Bergisch Gladbach, Germany) according to the 
manufacturer´s protocol. In brief, intestinal epithelial cells were isolated by disruption of 
the structural integrity of the epithelium using ethylenediamine Tetraacetic acid (EDTA) 
and dithiothreitol (DTT). Purity of individual IEC fractions was analyzed by flow cytometry 
on a FACSCalibur flow cytometer (B&D, Heidelberg, Germany) with Cellquest analysis 
software from Becton Dickinson. 
RNA was isolated from the purified small intestinal IECs using the TRIZOL method. Briefly, 
1ml TRIzol was added to 50-75 mg pestle homogenized tissue followed by vortexing, five 
minutes’ incubation at room temperature and addition of 200 µl chloroform. After mixing, 
incubation at room temperature for 2-3 min and centrifugation (12.000 g) at 4°C for five 
minutes was done. Further, the clear supernatant was mixed with 500 µl isopropanol 
followed by incubation at room temperature for ten minutes. After further centrifugation 
(12.000 g) at 4°C for ten minutes, the supernatant was discarded and the pellet washed 
with 1 ml cold 75 % EtOH followed by vortexing and centrifugation (7.500 g, 4°C, 5 min). 
The pellet was dried and dissolved in RNase-free water. RNA libraries were prepared 
using TruSeq v2 Kit (Illumina) according to manufacturer’s instructions. All samples were 
sequenced using an Illumina HiSeq 2000 sequencer (Illumina, San Diego, CA) with an 
average of 23 million paired-end reads (2x 125 bp) at IKMB NGS core facilities.  
RRBS methylome screening was employed in this study. In the protocol, purified DNA 
was well digested with MspI restriction enzyme. DNA oligos of known sequence and with 
known cytosine modifications were added to the digested DNA. PCR amplification of 
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bisulfite-converted reads was performed to generate the desired RRBS library. During this 
procedure, fragments bind on either side to a flow cell (solid glass surface) coated with 
specific oligonucleotides using their adaptors. The fragments hybridize with their 
complementary adapter and undergo bridge-amplification resulting in cluster synthesis of 
identical DNA fragments. The libraries were purified via magnetic beads (Ampure) 
employing acetonitrile instead of ethanol. The DNA was then converted with Cambridge 
Epigenetics (CEGX) TrueMethyl24-Kit according to the manufacturer’s handbook. The 
final libraries underwent size selection of greater than 180 bp via magnetic beads 
(Ampure). This step made sure to remove adapter dimers. The DNA was end repaired 
and A-tailed, followed by the ligation of barcoded next generation sequencing adapters. 
Library pairs were pooled together and three pairs were sequenced per lane on an Illumina 
HiSeq 2500 platform (Illumina, San Diego, CA) at an average of 127 million single-end 50 
bp reads at IKMB in Kiel, Germany. All RNA-seq and RRBS data have been uploaded to 
GEO with accession number [GEO:GSE94402]. 
 
2.2  Analytical pipelines  
This thesis includes several types of high-throughput data and its analysis. In the first 
twins study, microarray data analysis and preprocessing procedures were mainly 
developed by Häsler and Feng49 within Institute. For mouse study, the development and 
implementation of RRBS and RNA-Seq pipelines from the HiSeq sequencing platform 
were developed by Kachroo96 and myself. All data analysis were executed on the high 
performance computing cluster (HPC) of Kiel University on Linux system and mainly 
packaged into shell scripts and some independent scripts as and when needed, which 
can be modified or run in parallel for other similar projects. Data preprocessing, analysis 
for microbiota, gene expression, DNA methylation and integrated analysis will be covered 
in the following text. 
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2.2.1  16S rRNA gene data analysis 
The data preprocessing was followed the MiSeq standard operating procedure using 
software MOTHUR97 as suggested by lab of Dr. Schloss for processing paired-end reads 
of 16S rRNA gene sequences (https://www.mothur.org/wiki/MiSeq_SOP). The modified 
pipeline was shown in Figure 8. After data preprocessing, the bacterial composition across 
samples was displayed as a table with columns indicating samples and rows representing 
OTUs. Based on the table, the statistical method can be applied to have further novel 
insights on the microbial communities. The analysis flow chart is displayed in Figure 9. 
   
 
Figure 8  16S rRNA gene data preprocessing 
 
Sequences merging, reducing sequencing and PCR errors 
The first step of preprocessing is to match the paired sequences, combine the sequence 
data and also affiliating the sequences to corresponding sample. Mothur uses 
straightforward alignment algorithm for aligning the paired sequences (aka contigs). If a 
base has a disagreement, the one which has a quality score of 6 or more better than the 
other is chosen, otherwise the consensus base is set to ambiguous base (N). If one 
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sequence has a base and the other has a gap, the quality score of the base must be over 
25 to be considered real. The fasta and qual files were generated after alignment. The 
reads were then filtered out with improper assembly, which had a single ambiguous base, 
or long homopolymers of equal and/or more than 8 bases.  
 
Alignment, Pre-cluster and removing chimeras 
Consequently, the sequences were aligned against Mothur curated Sliva reference 
database (https://www.arb-silva.de) in defined 16S rRNA gene variable region V3 and V4. 
The sequences were only kept if they aligned to defined V3-V4 region. In order to de-
noise the sequences and reduce the computation loading, similar sequences which 
allowed only one difference for every 100 base were merged. After removing the 
sequencing errors by the above-mentioned procedure, next step was to remove chimeras. 
Chimeras are hybrid products between multiple parent sequences that can be falsely 
interpreted as novel organisms, thus inflating apparent diversity98. As suggested by 
Mothur pipeline, UCHIME algorithm99 was employed to detect and remove these chimeras.  
 
Clustering and classification of OTUs  
For a deeper and more accurate analysis, the sequences were assigned into operational 
taxonomic units (OTUs). Because the sequence-based recognition of uncultivated 
microbial populations is not equivalent to the traditional taxonomic classification, 
Sequences having at least 97% of homology were clustered as an OTU. Individual OTUs 
were classified phylogenetically using RDP dataset (trainset9). Furthermore, equal 
number of sequences were subsampled (smallest sequence size) to normalize the 
sequencing depth. This subsample procedure is essential to compare all samples onto 
the same standard. The final OTU table as obtained after subsampling was used for 
downstream statistical analysis (Figure 9). 
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Figure 9  16S rRNA gene data analysis 
The composition and structure of the microbiota in each sample can be represented through 
calculation of α-diversity and β-diversity metrics, or by other statistical analysis for different 
purposes (e.g. identifying differentially abundant taxonomic groups between sample groups). 
 
Alpha diversity 
From ecological point of view, alpha diversity is a measurement of the diversity of species 
within a sample. The sequencing depth (number of reads per sample) mainly affects the 
accuracy of the measured alpha diversity. Samples with a higher number of reads would 
show higher diversity than samples with a lower number of reads. This uneven sequencing 
depth might cause a bias in the interpretation of the results and lead to a misconstruction 
of the conclusions. Thus, read number normalization is important before going into any 
statistical analysis. Rarefaction analysis on the sample can find out whether the sequence 
depth is sufficient. If the sequence number is too low, one might discard the sample, or 
sequence it again to get better quality. The alpha diversity can also be divided into two 
categories: richness diversity and evenness diversity. Richness diversity estimators 
estimate the total number of species present in a community. Chao1100 is the most widely 
used richness index in the microbial community. In contrast to richness diversity, 
evenness diversity measures the relative abundance of the different species within the 
sample. It takes into account the number of present species, as well as the abundance of 
each species. The Shannon index (entropy)101 and Simpson index102 are the two most 
popular evenness diversity indices in the microbial literature. 
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Beta diversity 
The general definition of beta diversity is the distance, or dissimilarity, between each 
sample pair. Different beta diversity indices give different weights to rare species, in order 
to emphasize the role of rare species in the microbial composition between two sites or 
communities. Jaccard index is a useful measurement of calculating the overlapping 
species between two samples. It only takes into account the presence-absence of the 
species or OTU, giving the rare and abundant species the same weight in the index. Unlike 
the Jaccard index, Bray–Curtis dissimilarity quantifies the compositional dissimilarity 
between two samples based on the bacterial abundance. Beta diversity is bound between 
0 and 1, where 0 means the two samples have an identical composition, and 1 means the 
two samples do not share any species. By using different pairwise matrix of the beta 
diversity metrics, one can visualize the relative distance between all the samples in 
different ways, such as a tree or graph. In this thesis, Jaccard and Bray–Curtis were 
employed as the different distance bases in principal coordinates analysis (PCoA) to 
explore the similarities for presence-absence and abundance of the microbial data. 
 
Other statistical analysis 
Additional statistical analyses, such as plot for bacterial abundances, PERMANOVA, non-
parametric Wilcoxon test, and correlations with other attributes, were also included in the 
16S rRNA gene data analysis. In this study, all statistical analysis were undertaken by the 
statistical computing software R (https://www.r-project.org).  
  
2.2.2  RNA-Seq data preprocessing and analysis 
RNA-Seq is the most widely used method for estimating gene expression. It reveals the 
presence and quantity of RNA in a biological sample and takes into account the 
transcriptional heterogeneity among cell types, as suitable for my purpose. The pipeline 
of RNA-Seq analysis is very similar to RRBS (section 2.2.4 ), but compared to RRBS, 
RNA-Seq is more straightforward (Figure 10). 
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Figure 10 RNA-Seq data preprocessing and analysis pipeline 
Starting from the raw reads, the pink colored components correspond to the preprocessing part 
of the pipeline and the blue colored components correspond to the downstream analysis of the 
pipeline. 
 
Quality control 
The quality control step can perform a quality check of the data to get an idea of whether 
or not the experiment worked as expected. FastQC checked the general sequencing 
information, such as the distribution of reads at each position, GC bias, ambiguous N 
bases, sequence duplication, adapter or primer contamination etc. FastQC is a widely 
accepted tool to visualize the quality of the sequences 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). In a normal situation, the 
duplication rate should not be higher than 80%. The other important stage is read trimming. 
If contamination was observed from the presence of adapters or primers in the tail of the 
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reads, trimming is necessary. To do this, Cutadapt (https://pypi.python.org/pypi/cutadapt/) 
was introduced for sequence trimming.  
 
Mapping to reference genome 
Alignment is a crucial step to find the location from which the reads originated. The 
greatest challenge of RNA-Seq transcriptome alignment comes from the eukaryotic gene 
structure, which contains introns, insertions, deletions, alternative splicing, presence of 
pseudogenes and gene fusions. These diverse situations might lead to incorrect 
alignments.  Any mapping algorithm must be able to handle these huge gaps (splice sites) 
or other sources of error. Alignment or mapping to the reference genome for RNA-Seq 
data was performed using Tophat2103, which incorporates Bowtie2104. Bowtie2 extends 
the full-text index–based approach of Bowtie for efficient alignment in RNA sequences. 
After alignment, BAM files (the binary format of Sequence Alignment/Map format) were 
generated automatically from Tophat2. BAM files from Tophat2 mapped with mouse 
genes from the reference genome mm10. Ambiguous bases (Ns) in the reference, and 
sequences marked as duplicates, were ignored for the calculation. HTseq105 is then 
performed for the processed RNA-Seq alignments for differential expression calling. 
HTseq generates the counts for each gene and the number of aligned reads overlap its 
exons. These counts can then be used for gene-level differential expression analyses, 
such as DESeq2106, which was used in this study. 
 
Alternative splicing 
RNA-Seq has revealed an enormous complexity of alternative splicing (AS) across 
diverse cell and tissue types. There are five main classifications of AS types: skipped 
exon , alternative 3’ splice site, alternative 5’ splice site, mutually exclusive exons, and 
intron retention107(Figure 11). The differential alternative splicing tool: rMATS108 (repeat 
multivariate analysis of transcript splicing), which is specific for replicate RNA-Seq data 
was employed in this study. It performs a hierarchical framework to model exon inclusion 
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levels, this hierarchical model estimates uncertainty in biological replicates and variability 
across replicates.  
 
 
Figure 11 Five alternative splicing categories  
The five main classifications of AS types demonstrated as exon skipping, mutually exclusive 
exons, alternative 5‘splice site, alternative 3‘splice site, and intron retention. 
 
Differential expression analysis 
With the improvement of high-throughput sequencing technologies in genomic studies, 
the need of statistical methods for differentiating genes increases. High uncertainty of 
within-group variance is the main challenge while detecting the differential gene 
expression. This can be overcome by measuring information across genes, specifically, 
by estimating the similarity of the variances of different genes measured in the same 
experiment. Several tools, such as edgeR109, DSS110 and DESeq2106 all handle this issue 
in different ways. EdgeR moderates the dispersion estimate for each gene towards a 
common estimate across all genes by using weighted conditional likelihood. DSS uses a 
Bayesian approach to estimate the dispersion for individual genes, while considering the 
heterogeneity of dispersion values for different genes. DESeq2 not only detects dispersion 
estimates, but also corrects dispersion in low-read transcripts for averaging expression 
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strength over all samples106. For this analysis, DESeq2 was chosen based on a better 
false discovery rate (FDR) in the larger sample size and the outliers111. The expression 
counts were normalized by library size in DESeq2 for differential expressed analysis. 
 
2.2.3  Affymetrix microarray data preprocessing and analysis  
Affymetrix Human Genome U133 Plus 2.0 array was developed in 2003. A microarray 
contains oligonucleotide “probes” that bind to mRNA from a sample. There may be 
numerous probes from the coding regions of any given gene. This array provides 
comprehensive analysis of genome-wide expression on a single array. Quality 
assessment is essential in microarray and many probes need to be discarded during 
quality control processing. There are two major issues to be addressed during data 
preprocessing: background correction and normalization. 
 
Background correction 
Probe signal intensity is measured by auto fluorescence of the array surface, and also by 
some unspecific sources. Background correction methods estimate the background 
portion of the probe signals and subtract it accordingly112. Affymetrix chips are so dense 
that there is no space between two probes. Hence, it is not possible to measure the signal 
in the surrounding area, so the background noise must be estimated from the probe 
signals themselves. In the chip design, one can get two measurements: prefect match 
probes and mismatch probes. A perfect match probe matches a strand of cDNA, while the 
corresponding mismatch probe differs from the perfect match by a change in the central 
nucleotide. The MAS 5.0113 method developed by Affymetrix averages over regions in the 
array for both perfect match and mismatch probe cells. This algorithm builds a hierarchal 
model, which is used to design robust estimators for comparative experiments.  
 
Normalization  
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A chip effect is a bias of the raw probe signal measurement. This effect is chip specific 
and influences all probes on a given chip in a similar manner. It is caused by varying total 
RNA abundances, labeling and hybridization efficiency, scanner properties, and many 
other sources of variation. Non-biological factors can also contribute to the variability of 
the data. In order to compare data from multiple probe arrays reliably, differences of non-
biological origin must be minimized. The purpose of normalization is to remove all non-
biological effects. After normalization, variability between the different arrays is reduced 
and the changes in expression values becomes more reliable. R package GCRMA114 is 
employed for normalization method in this study. The main function of GCRMA is to 
convert background adjusted probe intensities to expression measures using 
normalization and summarization methods, such as robust multi-array average115. 
 
Statistical test 
In the twins study, non-parametric Mann-Whitney U-test was performed to determine the   
differential gene expression. Multiple testing correction was performed using the 
Benjamini-Hochberg116 method. The criteria for transcripts to be categorized as 
differentially expressed for corrected was p-value ≤ 0.05. 
    
2.2.4  RRBS data preprocessing and data analysis 
In general, RRBS data preprocessing might be challenging compared to the other 
techniques. Firstly, removal of duplicate reads might not be suitable in RRBS data analysis 
due to the CpG enrichment in the genome. However, the difference between PCR 
duplicates and enrichment-based duplication cannot be distinguished. Secondly, the 
failure of the bisulfite conversion rate might affect the data quality, thus spike-in controls 
is necessary for measuring the bisulfite conversion efficiency and to adjust methylation 
levels for each sample. Thirdly, RRBS samples are very sensitive to any technical biases, 
such as the concentration of the sample, library preparation and sequencing batch, mice 
litter, etc. Thus, one should be very careful from the beginning of the experiment to avoid 
any possible bias, especially the batch effect. Last, but not least, the resolution of the 
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methylation level is down to each single CpG site. Therefore, annotation is a very essential 
process. One needs to annotate all the positions to the available genes (intron, exon, gene 
body etc.), and regions (CpG islands, enhancer, shores, shelves, other regulatory regions 
etc.). The known reference genome (human or mouse) from a reference genome browser, 
such as UCSC or Ensemble, could be used in annotation. Thus, RRBS might not be a 
proper method for the methylation level measurement of a species with an incomplete 
genome reference. The preprocessing pipeline is visualized in Figure 12. Here, several 
packages were employed for this large-scale analysis. Incidentally, with this sophisticated 
data structure, one should also consider the heavy computational work and machine 
capacity.  
 
 
Figure 12 RRBS data preprocessing pipeline 
Data preprocessing starts from the raw data (*.fasta) and ends as a *.cov file, which includes the 
coverage and the methylation rate.  
 
Quality control 
The quality check procedure for RRBS data is almost the same as the procedure used for 
RNA-Seq data. Here, the quality control process mainly followed the instructions from 
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Epigenesys, which was built by Felix Krueger and Simon R Andrews117. As mentioned 
above, the duplication rate should not be higher than 80% in a normal situation. An 
abnormal high duplication rate might due to the PCR duplication, which should probably 
be removed before commencing with downstream analysis. However, a  high duplication 
level of 95% might be reasonable in RRBS library, since all fragments are expected to line 
up perfectly at exactly the same genomic location numerous times (there are only so many 
MspI recognition sites in a genome). Therefore, the duplication rate check could be 
temporarily ignored in RRBS library. 
 
Alignment and methylation calling  
Bisulfite converted reference data will have all unmethylated Cs converted to Ts, therefore 
it consists of three nucleotides: A, T and G. The aligned base T could be an unmethylated 
C or the original genomic base T. This characteristic further raises the complexity of 
alignment, and might create ambiguous results. In this study, Bismark118 was selected, 
among several alignment approaches, to handle this challenge. In Bismark, the bisulﬁte 
reads are first transformed into a C-to-T and G-to-A (reverse strand) version. Then, each 
of them is aligned to equivalently pre-converted forms of the reference genome using four 
parallel instances of the short read aligner Bowtie2 (Figure 13). Thus, all possible 
outcomes can be considered in the alignment process. The first mapping output of 
Bismark contains one line per read and provides information on the mapping position, 
alignment strand, bisulﬁte read sequence, its equivalent genomic sequence, and a 
methylation call string. This initial output can be converted into BAM files, or imported to 
a genome browser for visualization for further research purpose by the users. 
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Figure 13 Bismark’s approach to bisulﬁte mapping and methylation calling 
BS reads are converted into a C-to-T and a G-to-A version and are then aligned to equivalently 
converted versions of the reference genome. The best unique alignment is then determined from 
the four parallel alignment processes. Figure modified from: Krueger, Felix and Andrews, Simon 
R118 
   
After alignment, Bismark automatically calculates the methylated and non-methylated 
number in each detected CpG site. Ultimately, one can get the methylation-calling file with 
information on the CpG positions, methylated reads number, non-methylated numbers, 
and the methylation rate (percentage; number between 1 to 100) in each row. From this, 
one can calculate the coverage, which is a criterion for filtering the data with an alignment 
error in this initial step. There are three main steps in RRBS data analysis: sample merging 
and site filtering, differentially methylated site analysis and annotate to reference genome 
(Figure 14). 
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Figure 14 RRBS data analysis pipeline 
Downstream analysis of the *.cov file from preprocessing (Figure 12).   
 
Sample merging and site filtering 
In order to have a global view of the data structure, methylation information of the CpG 
sites across all samples need to be merge as a matrix. Memory efficient R package 
RnBeads119 provides the merge function specific for methylation data. Due to the huge 
number of missing value, multidimensional scaling (MDS) was performed for dimension 
reduction and pattern recognition problem. Unlike microarray data, the restriction enzyme 
Msp1 in RRBS only enriches the CCGG sequence; therefore, some CpG sites might be 
missing in certain conditions. Furthermore, the CpG sites, which aligned to the Y 
chromosome were removed by the female-only experiment design in this study. 
Additionally, the overall noise was greatly reduced with increasing coverage for each CpG 
site. Thus, the accuracy and statistical power of the results, strongly depends on the 
coverage of the methylation call120. However, the arbitrary cutoff depends on the quality 
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of data. Threshold of 5 was employed in this study, all CpG sites with coverage less than 
5 were removed. The last stage of preprocessing was SNP removal. The presence of 
SNPs inside the data can have important consequences, or mislead the downstream 
analysis, therefore, SNPs of C57BL/6(N) mice strand were removed. The SNP information 
is from mouse genome project (http://www.sanger.ac.uk/science/data/mouse-genomes-
project). 
 
Differentially methylated site analysis 
There are several free tools for identifying differentially methylated positions/region. 
RnBeads119, which is already included in previous merge stage, computes p-values by 
using hierarchical linear models from the limma121 package. It assumes that the number 
of reads from each single CpG site follow normal distribution. This assumption might not 
fit the real situation. The counts are binary (methylated or unmethylated) and sequenced 
with prior probability. Based on its character, the beta-binomial model is the first choice. 
Here, R package DSS110 (Dispersion shrinkage for sequencing data) was recruited for 
detecting the DMPs. This method borrowed the dispersion shrinkage approach from 
differential expression analysis in RNA-Seq and microarray analysis, by taking information 
from CpG sites across the genome, to stabilize the estimation of the dispersion 
parameters in lognormal-beta-binomial hierarchical model. 
 
Annotation to gene or genome  
For gene category annotation, MethylKit122 was performed. The methylation sites were 
annotated from UCSC mm10 mouse genome. The promoter region is defined as a 1,500 
base pair window from the center of the transcription start site. The positions were 
annotated in four gene categories: exon, intron, promoter and intergenic.   
  
Last but not least, it is always necessary to modify parameters of the pipeline according 
to the dataset, samples used and their quality, which can have some influence on the 
results.   
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2.2.5  HumanMethylation27 microarray data analysis 
Beadchip is used for methylation probes on the Illumina 27k methylation array. 
Quantitative measurements of DNA methylation are determined for 27,578 CpG 
dinucleotides spanning 14,495 genes123, including nearly 13,000 well-annotated genes in 
the NCBI CCDS Database (Genome Bulid 36) and over 1000 cancer-related genes, or 
targets. 
 
Quality Control and methylation measurement  
In order to get rid of the noise influence, the machine also calculates the “detection p-
value” for each probe., There is no significant difference between the real biological signal 
and the background noise if the detection p-value is higher than 0.05. The probes with 
detection p-value > 0.05 will be discarded for downstream analysis. For an individual CpG 
site, a pair of bead-bound probes is used to detect the presence of T (unmethylated state) 
or C (methylated state). In default, a beta value is used to measure the methylation level 
of a single CpG site, and is subsequently determined by calculating the ratio of the 
fluorescent intensities of the methylated probe (M) and unmethylated probe (U) according 
to the following formula: 
 
𝛽 =
max⁡(𝑀, 0)
max(𝑀, 0) + max(𝑈, 0) + 100
 
 
Here, max(M, 0) and max(U, 0) indicate the maximum value between M and 0, and U and 
0, respectively. The number 100 in the denominator is a constant offset to standardize 
beta values when both methylated and unmethylated probe intensities are low. The Beta 
value has a direct biological interpretation - it corresponds to the methylation percentage 
of a single CpG site. However, because the Beta-value has the upper bound 1 and lower 
bound 0, this statistic violates the Gaussian distribution assumption. Furthermore, from 
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an analytical and statistical standpoint, the Beta-value method has severe 
heteroscedasticity outside the middle methylation range, which imposes severe 
challenges in applying many statistic models124. Thus, instead of the Beta-value, M-value 
was invented by Pan Du and colleagues124. 
 
M = 𝑙𝑜𝑔2 (
max(𝑀, 0) + 1
max(𝑈, 0) + 1
) 
 
Although the M-value statistic does not have an intuitive biological meaning, it is possible 
to provide an accurate estimation of the methylation status by modeling the distribution of 
the M-value statistic. 
 
2.2.6  Integrated analysis in mouse study 
With the rapid development of NGS in different omics scale, integrated analysis in multiple 
omics would reveal novel biological hypotheses involving complex interactions among the 
different conditions. For other genomic statistical methods (e.g. GWAS, eQTL, mQTL), 
multiple comparisons, or association issues, also exist in traditional transcriptome-
methylome studies. Enormous comparisons with large noise weaken the statistical power. 
Hence, people use FDR (e.g. Bonferroni or Benjamin–Hochberg correction) or stricter 
standards (p-value<10-5 in GWAS) to filter out the signals with less significance. However, 
this approach ignores the fact that the two dimensions of multiplicity are not equivalent. 
Instead of massive calculations in the whole genome, the integrated analysis in mouse 
study focuses on the methylation patterns, which are close to the differentially expressed 
genes. The hierarchical testing approach125 (Figure 15) was applied to identify interactions 
between the microbiota dependent alterations in the transcriptome and DNA methylation 
signatures. Hierarchical testing approach controls overall FDR at a set level, and also 
controls for mixed-directional FDR at the individual level. By using this two-step approach, 
38 
 
DMP and DMR were detected sequentially, and it can furthermore avoid FDR penalty in 
different biological signals especially for this small sample size comparison (5 vs 5). 
All CpG sites of 5 kb up- and downstream of the transcription start of the microbially 
regulated genes were identified. Then, the neighborhood methylated positions were 
combined to methylated regions (maximum distance 200 bp). The regions with only a 
single point, or which contained less than 20% CpGs (p-value < 0.05), were excluded and 
all retained regions were considered as differentially methylated regions. In the end, the 
Benjamini–Hochberg procedure was performed to correct the FDR for retained regions 
(adjusted p-value<0.05). This filtering approach was well suited and beneficial for both 
DMR and DMP detection. Moreover, the essential biological signals can only be explored 
by avoiding the over-multiple correction.  
 
 
 
Figure 15 Hierarchical testing approach 
Integrated analysis workflow. The hierarchical testing procedure was employed to detect the 
interactions between gene expression and methylation in three developmental stages. 
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3.  Results 
This thesis encloses the results of two studies driven and interconnected by the used 
technologies and pipelines. The main findings of these two studies are described as stated 
in the following manuscripts.  
 
3.1  Twins study  
3.1.1  Study design 
The etiology is largely unclear in intestinal disease, however, genetics and environment 
has been considered to play the crucial roles for the pathogenesis. More and more 
studies49 revealed the importance of epigenetic modifications, it represents a major 
interface between internal and external factors. The main aim of the study was to 
present a high-resolution map of epigenetic modifications and host microbiota 
profile with potential disease relevant effects on the host transcriptome in 
ulcerative colitis. The underlying hypothesis of the study was therefore, that epigenetic 
change of UC-relevant genes results in altered gene expression and host microbiota 
composition modification with pathological consequences, contributing to disease 
mechanisms. Integrating these three layers into the current picture of ulcerative colitis 
disease pathophysiology may close the gap between genetic susceptibility, missing 
heritability and disease manifestation. Therefore, the mucosal biopsies of colon were 
sampled from monozygotic discordant twins for UC. RNA and DNA were isolated to study 
gene expression and DNA methylation pattern in relation to healthy and disease status. 
Subsequently, the observed difference in gene expression and microbial groups were 
validated in an independent cohort consisting of 20 UC patients and 20 healthy controls 
(Figure 16). 
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Figure 16 Study design of twins study 
UC: ulcerative colitis patients; H: healthy control; GE: gene expression; MB: microbiota; DM: 
DNA methylation. The layout of the strategy was to investigate the gene expression, methylation 
and host microbiota interaction in ulcerative colitis.  
 
 
3.1.2  Microbiota profile  
After data preprocessing and normalization for sequencing depth (mentioned in 2.2.1 ), 
292833 16S rRNA gene sequences resulted from five pair of twins. Analysis was 
performed in the host and microbial data which are available for both twin subjects. 211 
OTUs were classified up to genus level by using Silva database (https://www.arb-silva.de). 
The relationship between age and alpha diversity was first investigated, the difference of 
Shannon diversities between healthy and UC discordant twin subjects increases along 
with the time (Figure 17).The diversity of richness and evenness between healthy control 
and UC patients were compared (Figure 18). Either in richness or evenness, the 
diversities in healthy individuals are generally higher than in UC (mean estimator of 
Healthy control vs UC patients, Chao1 index: 150.26 vs 109.24; Shannon index: 3.31 vs 
2.77). Due to small sample size, the mean differences were not statistically significant, 
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although the diversity decrease pattern are obvious (Figure 18). PCoA plot was performed 
microbiota composition for observing the relationship between disease status and kinship. 
Bray-Curtis dissimilarly was used for PCoA analysis. This dissimilarly quantifies the 
compositional dissimilarity between two different sites based on read counts at each site 
(Figure 19). The first and the second principal components explained 22.89% and 16.47% 
variation of the composition respectively. The twin pairs were connected by solid lines in 
Figure 19. The pairs located in the proximity compared to the distance of unrelated 
individuals, this linking pattern showed the tight connection of the genetic effect on 
microbiota composition. SIMPER analysis126 (Similarity Percentages analysis) was 
applied to find the contribution of each species between two conditions. It calculates the 
contributions of similarities among sample groups, and provides the variable importance 
percentage of contributing similarity between factors. 60 bacterial genera were selected 
as the cutoff of 90% variation.  
 
Figure 17 Shannon Entropy from twins microbiota  
Every single circle indicates every individual. The difference between healthy and UC discordant 
twins increases along with the age.    
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Figure 18 Alpha diversity for Healthy and UC in twins study 
Here are boxplots of alpha diversity indices for healthy and UC discordant monozygotic twins. 
The connected points are from the same pair. (A) Chao1 index indicates the estimated bacteria 
species number of two conditions (B) Shannon index indicates the evenness of microbiota 
composition. Chao1 and Shannon index decreases generally in UC patients, except one pair.  
 
 
 
Figure 19 PCoA plot with Bray-Curtis distance in twins study 
The connected points indicate the twin pair. The twin pairs in the figure located in the close area.  
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3.1.3  Gene expression and DNA methylation 
The transcriptome analysis was performed from 20 monozygotic twins, discordant for UC. 
19,025 (out of 54,675) transcripts were considered as expressed. This study focuses on 
the genes with particular functions, the genes with descriptions including keyword 
Defense, or including the words which start from inflame and immune from GO database 
(Geneontology.org) were selected for the following analysis. Based on this filtering 
criterion, 967 transcripts (584 genes) were kept for downstream analysis. Furthermore, 
117 transcripts (97 genes) were differentially expressed (t-test p-value<0.05; fold change 
FDR<0.05) between healthy and UC subjects. GO analysis was performed to detect the 
encoded biological processes: regulation of inflammatory response (p-value=6.90E-4) 
and positive regulation of cell junction assembly (p-value=7.22E-4) were significant as the 
related biological process for the candidate genes. Hierarchical clustering was further 
performed to identify gene clusters, resulting in a heatmap (Figure 20). UC patients 
clustered together, as shown in the left side of the figure. The kinship is also partially 
evident in the figure, some twins also clustered together (UC_07a, H_07b & UC_12a, 
H_12b).  
These selected genes were then compared with the result of similar experiment setting 
from Kugathasan S and colleagues127. Kugathasan’s study investigated RNA expression 
from colon biopsy in unrelated 10 UC pediatric patients and 11 healthy controls by using 
microarray. Based on the same filtering criteria and the statistical test, 456 transcripts (337 
genes) were identified as differentially expressed between healthy and UC subjects in 
Kugathasan’s study (Figure 21). With comparing the results in both studies, there were 
64 genes overlap between two studies.  
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 Figure 21 Differently expressed gene in both studies 
The number in the circle means the number of differently expressed genes. This twins study 
recruited 10 pair discordant UC twins while Kugathasan recruited 10 UC and 11 healthy controls. 
 
 
Figure 20 Heatmap of differentially expressed transcripts  
H: healthy control groups, UC: ulcerative colitis patients. The numbers followed the disease 
status in the column labels were the label of twin pairs. The subjects that shared the same number 
were the twin pairs.  
 
 
45 
 
Furthermore, for the DNA methylation analysis, out of 27578 CpGs, 23085 were detected 
in this dataset. Among all informative CpGs, 382 methylation positions located in close 
proximity (±50 kb) to these 117 differently expressed transcripts. The correlations were 
calculated in methylation position and transcripts, to investigate the epigenetic 
modification influencing of gene expression. High correlation (spearman correlation |ρ| 
>0.6) was seen in 18 methylation positions with 17 transcripts (15 genes: S100A8, AGT, 
IRAK2, TNFSF10, CXCL6, C2, CFB, CCL24, LYN, PRDX5, OAS1, ISG20, ABR, CCL11, 
PRDX2). Regulation of inflammatory response showed statistical significant in GO 
analysis for these selected 15 genes.  
Transcript ID Gene 
name 
cg number 
(methylation) 
chromosome cg position correlation 
202917_s_at S100A8 cg02813121 1 151615535 -0.752941176 
202834_at AGT cg06585893 1 228950175 -0.758823529 
231779_at IRAK2 cg20916523 3 10159584 -0.785294118 
202688_at TNFSF10 cg11979312 3 173725407 -0.602941176 
206336_at CXCL6 cg02029926 4 74953738 0.714705882 
206336_at CXCL6 cg22670329 4 74920939 -0.644117647 
203052_at C2 cg09583599 6 32033899 -0.629411765 
202357_s_at CFB cg01883966 6 32046865 -0.638235294 
221463_at CCL24 cg05556717 7 75257240 -0.714705882 
202626_s_at LYN cg03973663 8 56954130 -0.620588235 
222994_at PRDX5 cg11296937 11 63841542 0.708823529 
1560587_s_at PRDX5 cg11296937 11 63841542 0.685294118 
1560587_s_at PRDX5 cg13412615 11 63814383 0.723529412 
205552_s_at OAS1 cg19789466 12 111829306 0.605882353 
33304_at ISG20 cg08491125 15 86982946 -0.65 
204698_at ISG20 cg08491125 15 86982946 -0.694117647 
212895_s_at ABR cg25374854 17 1030708 0.788235294 
210133_at CCL11 cg11860203 17 29606629 -0.785294118 
39729_at PRDX2 cg08694544 19 12807228 -0.638235294 
 
Table 1 Highly correlated expression-methylation genes in twins study 
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3.1.4  Integrated with microbiota 
The microbiota plays a fundamental role on the induction, training and function of the host 
immune system. After discovering the methylation-related genes, the next goal was to 
identify the potential bacterial genera which related to these candidate genes. The 
correlation between all 60 bacteria OTUs and 17 transcripts was calculated. The heatmap 
from hierarchical clustering was plotted to have an overview of the interaction between 
host transcript and microbiota (Figure 22). Genes and OTUs can be majorly divided to two 
groups (Gene group1: ABR2, PRDX2, PRDX5; Gene group2: S100A8, AGT, IRAK2, 
TNFSF10, CXCL6, C2, CFB, CCL24, LYN, OAS1, ISG20, CCL11. OTU groups: omitted).  
The OTU group1 on the top in the figure has the positive correlation with gene group1, 
but negative correlation with gene group2, vice versa for the down OTU group2.    
 
Figure 22 Heatmap showing the correlation between OTUs and transcripts 
Each row represents one OTU and each column represents each targeted gene. The genes can 
be separated to two groups base on the correlation pattern.  
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Several OTUs were identified to have the stronger correlation patterns with methylation-
related genes (more than 6 correlation values >0.5 or < -0.5.) compared to the other OTUs, 
17 OTUs were chosen as potential candidates related to methylation mechanism. Ten of 
them belong to Firmicutes and four of them are phyla Bacteroidetes (Figure 23). The detail 
of these OTUs up to genus level was described in Table 2.  
In summary, multi-omics approach (transcriptome, methylome and microbiota analysis) 
has been employed in this study. 17 immune function related transcripts (15 genes), 18 
methylation positions and 17 OTUs were identified with the potential interacting with each 
other in UC. The next step was to validate these findings in independent cohort.  
 
 
genus number of 
OTU 
Akkermansia 1 
Alistipes 2 
Bacteroides 1 
Barnesiella 1 
Blautia 1 
Clostridium_XlVa 2 
Dialister 1 
Dorea 1 
Desulfovibrio 1 
Lachnospiracea 
_incertae_sedis 
1 
Ruminococcus 1 
Sutterella 1 
un_Bacteria 1 
un_Lachnospiraceae 1 
un_Ruminococcaceae 1 
 
 
Figure 23 Selected OTUs in phylum level   
Table 2 Selected OTUs in genus level 
17 OTUs were selected as the potential disease and methylation related bacteria. These 17 OTUs 
belong to 5 phyla and 15 genera. 
 
 
48 
 
3.1.5  Validation  
15 disease- and methylation-associated genes and 3 bacterial OTUs were subjected to 
further validation and replication in a larger collection of sigmoid colon biopsies from the 
intestinal mucosa. This validation for mRNA expression and microbiota were performed 
by TaqMan-based real-time PCR and methylation validation was performed by amplicon 
sequencing in unrelated UC patients (n=20) and healthy controls (n=20). This cohort was 
chosen by the same gender proportion as the twins cohort (20% female and 80% male), 
however, the age of validation cohort are relative younger than the original panel (age 
group between 20 to 40). Gene expression analysis was first examined in 15 candidate 
genes, the one which has the same expression pattern as the original panel then further 
kept for the methylation and microbiota validation (Figure 24). 
 
Figure 24 Validation working flow 
 
Gene expression levels were measured by Taqman qT-PCR. After normalization from 
house-keeping gene ACTB, eight genes (LYN, TNFSF10, OAS1, AGT, CFB, S100A8 and 
CCL11) out of 15 were validated as differentially expressed between UC and healthy 
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control (t-test p-value<0.05, same direction for up/down regulation, Table 3 & Figure 25). 
The expression level of these eight genes were all higher in UC (Figure 25). The amplicon 
sequencing was further employed to assess the DNA methylation level on the CpG sites 
around these eight genes. Methylation level were measured in the 200 base window 
around the microarray-identified CpG sites. S100A8 was excluded because of the bad 
sequencing quality. Four CpG sites (in the adjacency area of three genes) were found 
differentially methylated between healthy control and UC (p-value < 0.05). Besides, the 
correlation between the methylation level and gene expression for these four CpG sites 
showed the same direction as previous twins panel (Table 4 & Figure 26). Microbiota 
information from this cohort were also measured by Taqman and went through the same 
preprocessing as mRNA expression. Correlation between three bacterial genera 
(Clostridium_XlVa, Bacteroides, Ruminococcus) and eight differentially expressed genes 
were calculated. Clostridium_XlVa and Bacteroides showed the similar correlation pattern 
with the previous panel (Table 5). Clostridium_XlVa had positive correlations with gene 
expression while Bacteroides showed the opposite direction.  
In summary, eight out of 15 genes were validated as differentially expressed; three of 
them have been identified as epigenetic-associated genes from correlation analysis 
between gene expression and DNA methylation. Besides, two bacterial genera were 
found with highly correlation with validated differentially expressed genes in the technically 
and biologically validation cohort. 
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Gene name 
 twins cohort  validation cohort 
p-value Up/down regulation p-value Up/down regulation 
ISG20 0.0044 / 0.0035 up 0 up 
LYN 0.001 up 0.0001 up 
TNFSF10 0.05 up 0 up 
OAS1 0.0025 up 0 up 
AGT 0.0027 up 0 up 
CFB 0.0124 up 0.0004 up 
S100a8 0.014 up 0 up 
CCL11 0.002 up 0 up 
 
Table 3 mRNA validation in independent cohort 
Eight genes out of 15 were validated in the independent large cohort with the same direction of 
gene expression (up or down regulation). There are two transcripts in ISG20, both of them showed 
significant in original panel. Up means higher in UC, down means higher in Healthy.   
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Figure 25 Differentially expressed gene in validation cohort 
The gene expression of ISG20 (Interferon Stimulated Exonuclease Gene 20), LYN (LYN Proto-
Oncogene, Src Family Tyrosine Kinase), TNFSF10 (Tumor Necrosis Factor Superfamily 
Member 10), OAS1 (2'-5'-Oligoadenylate Synthetase 1), AGT (Angiotensinogen), CFB 
(Complement Factor B), S100A8 (S100 Calcium Binding Protein A8) and CCL11 (C-C Motif 
Chemokine Ligand 11) are all higher in UC in both panels. 
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Gene name CpG site 
Correlation P-value 
twins cohort validation cohort validation cohort 
TNFSF10 cg11979312 -0.6029 -0.2375 0.0122 
CFB cg09583599 -0.5004 -0.5043 0.0431 
CFB cg01883966 -0.6382 -0.4255 0.0062 
LYN cg03973663 -0.6093 -0.2705 0.0122 
Table 4 methylation validation 
Three genes LYN, TNFSF10 and CFB were found as epigenetic-related genes with same 
correlation pattern in both twins and validation panels. 
 
 
Figure 26 The scatter plot of TNFSF10 and the correspond methylation sites 
The scatter plot of TNFSF10 and methylation site (cg11979312) in twins and validation panel. 
Both figure showed the negative correlation between gene expression and DNA methylation. The 
x-axis is the relative gene expression value (the value from microarray in twins cohort and from 
Taqman in validation cohort) and y-axis is the methylation level (M-value in twins cohort and beta-
value in validation cohort) 
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bacteria genus Gene name 
Correlation 
twins cohort validation cohort 
Clostridium_XlVa S100A8 0.683792236 0.44145658 
Clostridium_XlVa TNFSF10 0.489319215 0.4051866 
Clostridium_XlVa CFB 0.59596571 0.4537696 
Clostridium_XlVa OAS1 0.213292991 0.4482985 
Clostridium_XlVa ISG20 0.664972266 0.5019149 
Clostridium_XlVa CCL11 0.777892085 0.4277273 
Bacteroides TNFSF10 -0.342649337 -0.3722326 
Bacteroides CFB -0.756414575 -0.4741088 
Bacteroides LYN -0.769344739 -0.5540338 
Bacteroides ISG20 -0.588322447 -0.4641651 
Bacteroides CCL11 -0.226277864 -0.3525328 
 
Table 5 OTUs validation 
Two genera, Bacteroides and Clostridium_XlVa were validated with the same trend correlating 
with the disease and methylation –related genes. 
 
 
3.2  Mouse study  
3.2.1  Study design 
IECs study is substantial in investigating intestinal physiology and pathology17. IECs in the 
small intestine are focused in this study because of importance for several human 
disorders like inflammatory bowel disease (IBD) or cancer17. Our aim was to explore the 
bacterial effect on dynamic host epigenetic markers along with gene expression 
changes during the postnatal duration. Therefore, IECs were collected from 
conventionally-raised and germ free C57BL6 female mice at three different postnatal 
stages: week 1, week 4 and week 12/16 (W1, W4, W12/16), which represented the infant, 
juvenile and adult gut (Figure 27A). RNA and DNA were isolated for the purpose of gene 
expression and DNA methylation analysis. RNA and DNA were subjected to fuencing and 
reduced representation bisulfite sequencing to assess global mRNA expression and 
methylation, respectively (Figure 27B). After data pre-processing, there were 21619 
genes and around 12 million methylation sites employed in the downstream analysis.  
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Figure 27 Study design of mouse study 
(A) Conventional-raised (CONV-R) and germ free (GF) mice were chosen respectively and 
sacrificed in three developmental stages: week1, week4 and between week12 to 16. (B) The 
intestinal epithelial cells (IECs) from small intestine were collected. Though the next 
generation sequencing, isolated DNA and RNA are used for measuring gene expression and 
DNA methylation. 
 
3.2.2  Microbiota Profile 
Data Quality 
In order to investigate the microbial composition in small intestine of CONV-R mice, the 
16S rRNA genes were amplified and sequenced by Illumina MiSeq (2 X 300 bp). The 
resulting 119603 sequences were cleaned through data preprocessing by MOTHUR128 v 
1.37.6 (details were described in 1.7.1 One sample was discarded from subsequent 
analysis because of low number of sequence reads. The remaining samples were further 
normalized by subsampling the reads number down to 1691 reads (the smallest reads 
number for the remained samples). The sequences were then clustered into Operational 
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Taxonomic Units (OTUs) level, based on 97% similarity. In this study, 1392 OTUs were 
classified down to genus level by Silva database (https://www.arb-silva.de). 
 
Alpha diversity and composition 
Alpha diversity measurements were applied to determine the aspects of within-sample 
bacterial diversity that may be influenced by different conditions. The alpha diversity 
generally describes the species composition within the sample. Three measurements of 
alpha diversity are commonly used: rarefaction curves, species richness estimators, and 
community evenness diversity indices. 
Rarefaction curves were used to estimate and compare bacterial richness among different 
conditions with a distance cutoff level of 97% similarity (Figure 28). All amplified 
rarefaction curves increased rapidly from 0 to 2000 sequences, indicated that sequence-
derived diversity and richness in this study were sufficient to characterize the species in 
each samples. The rarefaction curves showed that the bacterial richness were higher in 
the later time points compared to W1.  
 
56 
 
 
Figure 28 Rarefaction curves for 16S sequencing 
The rarefaction curve, plotting the number of observed OTUs as a function of the number of 
clean sequences 
 
The OTU were classified to have the deeper knowledge of intestinal bacterial phyla. Figure 
29 showed the relative abundance of eight bacterial phyla (Actinobacteria, Bacteroidetes, 
Firmicutes, Fusobacteria, Proteobacteria, Tenericutes, TM7 and unidentified Bacteria). 
These phyla were found within the small intestine samples across all time points. 
Firmicutes almost dominated all small intestine ecosystem in newborn mice and the 
Bacteroidetes percentage increased with ontogenies period. Apart of these two main 
bacterial phyla, the percentage of Proteobacteria also raised up along with the time points. 
The individual variation for biological replicate within subgroups is obvious in W4 and 
W12/16. One sample in W4 and the other two subjects in W12/16 showed the clearly drop 
in Bacteroidetes compare to the other members within the group. 
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Figure 29 Phylum distribution of the microbiota of the 14 mouse samples at all-time point 
The distribution of the microbiota composition in different development stage. Firmicutes and 
Bacteroidetes were two dominated phyla in gut microbiota composition   
 
Species richness index estimates the number of species and evenness diversity index 
measures the relative abundance of different species in the given sample. Chao1 index 
and Shannon entropy index were employed as richness and evenness diversity in this 
study, respectively. Both diversity indices in W1 were lower than W4 or W12 (Figure 30). 
The diversity indices increased significantly from W1 to W4 or W12/16 (Table 6). However, 
there is no statistical difference between W4 and W12/16 in both indices. These results 
implied that the species number and composition structure of intestinal microbiota 
changed subsequently from early postnatal stage (W1) and then remained relatively 
stable from W4 to W12/16. 
58 
 
 
Figure 30 Chao1 richness and Shannon evenness diversity 
(A)Chao1 richness estimator estimates the total number of OTUs, and (B)Shannon index 
estimates the entropy of data composition. Both figures showed that either the richness or 
evenness change in the earlier period, and getting stable from W4  
 
 
  P-value of Chao1 index  
P-value of Shannon 
index 
Timepoints W4 W12/16 W4 W12/16 
W1 0.00323 0.01413 0.01442 0.02412 
W4   0.826   0.6888 
W12/16         
 
Table 6 P-value for each comparison between time points in alpha diversity index 
We use two tailed t-test for testing the mean difference between groups. The significant values 
(p<0.05) are highlight as red. 
 
Beta diversity 
The other goal of microbiological study was to compare the similarity/dissimilarity between 
bacterial composition in different conditions, such as antibiotic treatment or at different 
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time points during development. Beta diversity is the distance-base measurement for both 
presence/absence and abundance data in ecological studies. In this study, Jaacard and 
Bray-Curits were employed for calculating the similarity distance between samples. The 
structure of the relative distances between samples was projected in 3-dimensional plot 
by using a Principal Coordinate Analysis (PCoA) with first three principal coordinates. This 
method can focus on the most important axes and investigate the relationship between 
figure pattern and experimental factors.  
Figure 31 showed the PCoA plot of Bray-Curtis distance of the mouse samples. Each dot 
represents one individual. First three principal coordinate (Bray1, Bray2, Bray3) explained 
80% variation of total data structure. The first principal coordinate (Bray1) separated W1 
with other two time points and explain 38% variation in data structure. This separation 
matched the observations which were found earlier in alpha diversity indices. The 
separation between W1 and W4 can be explained by the plane of Bray1 (38%) and Bray 
2 (26%). Moreover, the samples from W12/16 contributed around 16% variation (Bray3) 
in microbial comoposition. The pattern of Jaccard based PCoA was similar to Bray-Curtis 
based PCoA (Figure 32). The first three principal coordinates of Jaccard distance 
(Jaccard1, Jaccard2, Jaccard3) explained only 52% variation. Samples from W12/16 
spilled out in this 3-dimensional space, on the other hand, W1 and W4 were clustered on 
the plane of Jaccard1 (24%) and Jaccard3 (12%). The results of either presence/absence 
or abundance distance based PCoA suggested that microbiota composition pattern in 
matured mammalian (W12/16) gut and developing stage (W1 and W4) were very distinct. 
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Figure 31 PCoA plot with Bray-Curtis distance 
The first and the second principle component explained around totally 64% variation, and the 
third component which is mainly from W12/16, explained 16% of variation in the data. 
 
 
Figure 32 PCoA plot with Jaccard distance 
The pattern is similar with Figure 31,  and the first and third component explained around only 
36% variation, and the second component which is mainly from W12/16 explained 16% of 
variation in the data. 
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3.2.3  Gene expression 
Data Quality 
The pre-processing pipeline in 2.2.1 (Figure 10) was applied in this study. As a first step 
in processing, the illumina adapters were trimmed from the raw reads. The trimming of 
adapters leaded to the improvement of read quality (Figure 30A,C). Reads were mapped 
to the mouse genome (MGI assembly version 10) using Tophat2103 program. On an 
average, more than 16 million reads (570 mio. total reads) were mapped per transcriptome 
library to mouse genome (Figure 34A). The average mapping rate was 83.3% (Figure 
34B). Subsequently, HTSeq was used to generate the read counts of 21,619 Mouse 
genes using the following parameters (mode: intersection-strict., minaqual: 20). The read 
counts of these 21,619 genes were employed in further downstream analyses. 
 
(A) Adapter content before trimming 
 
(B) Adapter content after trimming
 
(C) Per base quality before trimming 
 
(D) Per base quality after trimming 
 
Figure 33 Quality check before and after trimming  
Sample E0376 forward sequence was taken for the trimming example (A,B) Adapter content 
plot before and after trimming from FastQC. Before trimming, the percentage of illumina 
universal adapt is abnormally higher in the tail. After trimming, the adapter content is 
disappear. (C,D) Per base quality plot before and after trimming from FastQC.  
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(A)   Number of aligned reads 
 
(B)   Mapping rate 
 
Figure 34 Alignment reads number and mapping rate 
Average number of aligned reads for RNA-Seq is 19155018 (15490672-22929203, median 
= 18627290); Average alignment rate for RNA-Seq was 83.3% (73.3%-89.9%, median = 
85.7%) 
 
PCA and differentially expressed analysis 
Principal Component Analysis was performed to visualize the sample clustering based on 
the expression data of the 21,619 genes. The gene expression levels were normalized by 
library size. Samples clustered both according to the developmental stage and microbial 
status (Figure 35). The first principal component explained 63% variation and separated 
samples from W1 and the other two stages W4 and W12/16 indicating that gene 
expression changed dramatically during IECs maturation, especially after the very early 
postnatal period. Whereas, the second principal component explained 8% of variation and 
separated W4 and W12/16 but also CONV-R and GF within a single developmental stage. 
14
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Notably, the distance between CONV-R and GF samples increased along with the time 
from W1 to W12/16.  
 
 
Figure 35 Principal component analysis displaying the overall gene expression profiles 
across all samples.  
The first dimension explained 63% variation and separated W1 and the other two stages. The 
second dimension explained 8% variation and separated both W4 versus W12/16 and samples 
of a stage for their microbiota status. 
 
We then test for differentially expression between CONV-R and GF in three fixed time 
points. We detected 56 microbially regulated genes in W1 (differentially expressed in 
CONV-R vs. GF comparison with adjusted p-value < 0.05 and absolute log2-fold change 
> 1), 614 in W4 and 1084 in W12/16 (Table 7, Figure 36A). Moreover, the expression 
differences between CONV-R and GF (fold change) of the microbially regulated genes 
increased simultaneously with time (Figure 36B). Thus, mainly ontogeny (developmental 
stage) and to a lesser extend bacterial status determined the epithelial transcriptional 
profile during postnatal development. To gain insights into the biological functions of the 
microbially regulated genes during postnatal development, we employed Gene Ontology 
(GO) enrichment analysis on the differentially expressed genes in the three 
developmental stages. GO terms were mainly enriched in immune response related or 
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metabolic functions. Biological functions such as cellular response to interferon-beta, 
defense response to another organism, immune response were enriched in both W4 and 
W12/16. Positive regulation of NF-kappaB transcription factor activity and MyD88-
dependent toll-like receptor signaling pathway were enriched in W12/W16. 
 Number of DE Up-regulated Down-regulated 
W1 56 47 9 
W4 614 348 266 
W12/16 1084 613 471 
Table 7 number of differentially expressed gene in three fixed time points  
 
 
Figure 36 Differential expressed gene 
(A) Numbers of differentially expressed genes intersection, adjusted p-value<0.05, fold change 
>2 (B) MA plot of CONV-R vs GF for three different time points. Every dots represent one 
gene, x-axis is the mean expression value and y-axis is the fold change between CONV-R vs 
GF. The red dots indicated the statistically significant genes.  
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To identify gene clusters modulated by the microbiota we selected the 200 most significant 
bacterially regulated genes individually from the three pairwise comparisons of the 
developmental stages with the GF mouse (W1: CONV-R vs GF; W4: CONV-R vs GF; 
W12/16: CONV-R vs GF), created the union of these genes (n = 547 genes), and 
performed hierarchical clustering which resulted in a heatmap of clusters of microbially 
regulated genes (Figure 37A). A similar analysis was performed based on the selection of 
developmentally regulated genes for the two bacterial conditions CONV-R and GF 
(CONV-R: W1 vs W4; CONV-R: W4 vs W12/16; GF: W1 vs W4; GF: W4 vs W12/16) to 
create a heatmap with clusters of developmentally regulated genes (n = 553 genes, Figure 
37B). Both analyses reveal a microbial effect (e.g. clusters 2, 3, 4, 8, 11 in Figure 37A), 
and a developmental effect (e.g. clusters 8, 10 in Figure 37A). However, while the 
developmental effect is clearly visible in the heatmap of microbially regulated genes 
(Figure 37A), the microbial effect is not obvious in the heatmap of developmentally 
regulated genes (Figure 37B). This might be beause of the fact  that the developmental 
effect on the epithelial transcriptome is greater than the microbial effect (Figure 37B). 
Cluster 8 in Figure 37A contains microbially responsive genes that mainly have functions 
in immune responses and are induced by the microbiota and the effect increases during 
development. Notable genes of this cluster include Duox2 (dual oxidase 2), Reg3g 
(regenerating islet-derived protein 3 gamma), Nos2 (inducible nitric oxide synthase), Saa1 
(serum amyloid A-1) and Saa2, which have been reported previously as microbially 
induced in IECs19. The clusters 3 and 4 in Figure 37A contain genes such as Sdr16c6 
(short chain dehydrogenase/reductase family 16C, member 6) or Fn3k (fructosamine 3 
kinase), which are associated with metabolic functions, and expression of these genes is 
repressed by the microbiota.  
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Figure 37 Heatmap of bacterially and developmentally regulated genes 
 
Transcription factor binding site analysis 
Transcription factor binding sites prediction and identification throughout genomes are 
integral for understanding the details of gene regulation and for inferring regulatory 
networks129. We employed transcription factor binding site enrichment analysis from 
innateDB database among the promoters of microbially regulated genes to investigate the 
regulatory networks that underlie the microbiota induced transcriptome alterations. 
Interestingly, the transcriptional regulators most enriched among promoters of microbially 
regulated genes were unique to W1 whereas W4 and W12/16 shared several transcription 
factors (Figure2B). For example, in W1 the transcription factor XBP1, which functions in 
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ER stress, cellular proliferation and differentiation and protects from intestinal 
inflammation130,131, was enriched in the promoters of genes upregulated by the microbiota. 
Egr1 transcription factor was enriched in W4 upregulation genes. Egr1 induction in animal 
models implies complex responses such as inflammation, and fibrosis132. Raised Egr-1 
was also found in mice model in the gut with chronic experimental colitis133.In W4 and 
W12/16 the transcription factor HIF1, which functions in mediating hypoxia effects and 
regulates metabolism and immune responses134,135,136, was enriched among 
downregulated genes.  
 
 
 
Figure 38 Transcription factor binding site analysis 
Transcription factor binding sites enriched among microbially regulated genes (differentially 
expressed in CONV-R vs. GF) for each of the three developmental stages. The bar plot depicts 
the 15 most significantly enriched transcription factors of either up- or downregulated genes. 
 
Co-expression network analysis 
The genes that have similar expression patterns across the different condition are 
assumed to have the functional relationship137. These co-expression genes do not 
necessarily have causal relationship between each other, but more and more studies 
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showed the co-expression genes might related to some biological processes or pathways 
137. I further investigated the micrcobiota influence during postnatal development by co-
expression network analysis138. 970 co-expressed genes were selected based on 
correlation cutoff of 0.8, normalized by their expression level and tested for up/down 
regulation compared to the average expression. Differential nodes were then highlighted 
and GO analysis was performed to identify the encoded biological processes (Figure 39). 
This co-expression network analysis was done by the cooperation partner Dr. Thomas 
Ulas. At the W1 stage, we did not detect a microbiota-dependent node but a cluster of 
enriched genes in both CONV-R and GF. Genes of this group A were involved in cell 
differentiation and basic epithelial maintenance. At the W4 stage, group B genes involved 
in innate immunity were upregulated in CONV-R and group C genes encoding metabolic 
functions were upregulated in GF. During W12/16 group D genes functioning in adaptive 
immunity displayed strong microbiota dependency. 
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Figure 39 The microbiota modulates distinct functional expression nodes during 
postnatal development. 
Co-expression network analysis (CENA) was performed based on 970 co-expressed genes 
(correlation factor greater than 0.8 across all conditions). Each dot represents a gene and the 
color indicates its expression compared to the average gene expression level (red = up, blue = 
down). This analysis was from a collaborative approach with Thomas Ulas, Bonn. 
 
 
3.2.4  Alternative splicing 
Alternative splicing is a key molecular mechanism that creates diverse RNA isoforms from 
a single gene, potentially increasing protein variety. More and more evidence suggests 
that alternative splicing has the relation with colon cancer progression139,140. However, the 
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connection between gut bacteria and alternative splicing events has not been well 
discovered. In this study, the microbial effects on alternative splicing events in postnatal 
period was investigated. Five categories alternative splicing were classified by rMats108 
software: exon skipping, mutually exclusive exons, alternative 5′ splice site, alternative 3′ 
splice site, and intron retention (Figure 11). The significant differences was not observed 
in the overall alternative splicing patterns between CONV-R and GF in the three 
developmental stages (Chi-square test, p-value = 0.99, Figure 40 & Table 8) , that means 
the global alternative splicing trend might not directly connect to gut microbiota. Then the 
comparison was performed for the different alternative splicing event between CONV-R 
and GF in three developmental statuses, few specific events were significantly different, 
for example, the number of microbiota-dependent intron retention events was 2.3-fold 
higher in W1 compared to W4 or W12/16 (Figure 41). Intron retention has been thought 
to be a result of mis-splicing, but more and more studies recently revealed the importance 
of developmental stages and occurs in notably cancer141. Here the microbiota effect for 
intron retention was discovered, especially in early gut development.  
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Figure 40 The composition of AS events in all conditions 
 
 
CONV-R GF  
W1 W4 W12 W1 W4 W12 
SE 6690 6422 6423 6884 6614 6527 
A5SS 1152 1100 1119 1158 1139 1118 
A3SS 2037 1978 1972 2071 2019 1998 
MXE 351 348 333 353 345 335 
RI 2212 2198 2185 2236 2204 2197 
 
Table 8 AS events in all condition 
The distribution of 5 different categories alternative splicing events in all condition. There is 
no significant difference between CONV-R and GF (Chi-square test, p-value = 0.99) 
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Figure 41 Differentially AS events in fixed time points 
The significant event between CONV-R and GF in five alternative splicing categories. The 
number of significant retained intron events in W1 were significant higher than the other 
weeks. 
 
 
3.2.5  DNA methylation  
To investigate whether postnatal development or the microbiota affect the DNA 
methylation pattern of IECs, RRBS was applied to measure the methylation level of 
isolated IECs from CONV-R and GF mice at W1, W4 and W12/16.  
 
Data Quality  
TrueMethyl®Seq Kit from Cambridge Epigenetix was used for RRBS library preparation. 
The sequencing controls were spiked into the genomic DNA sample during NGS-library 
preparation (prior to adapter ligation). Each duplex contains C, 5mC, 5hmC and 5fC bases 
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at known positions, which can be interrogated after sequencing to give a quantitative 
assessment of the efficiency of conversion. The conversion efficiency was calculated after 
adapt trimming and alignment (Figure 12). Among all 30 samples, 7 of them had higher 
conversion rate (> 10%) in 5hmC which showed the failure of bisulfite conversion in 5hmC. 
Thus, failure samples resequencing is essential in this case. After resequencing, there 
was still one sample (in the group of W1/CON) can’t pass the quality control in the second 
run. The rest 29 samples were employed in the downstream analysis. SNPs (C57BL/6 in 
dbSNP dataset) were filtered out and masked the CpG site which the coverage lower than 
5. Totally 1,296,536 CpG sites were detected across all samples (Table 9).  
 
Sample groups Average mapping 
efficiency 
Average CpG sites Average CpG sites 
 >5x coverage 
W1 69.46% 2385443.5 1136155.2 
W4 72.09% 3383208.4 1016776.4 
W12/16 71.88% 2862948.6 1022393.4 
W1 69.94% 1928314.6 1123435.6 
W4 72.50% 2827844.4 981752.4 
W12/16 71.92% 2490268.4 1061716.4 
 
Table 9 Mapping efficiencies and CpG coverage of libraries  
 
 
NMDS and differentially methylation analysis 
The overall methylome pattern (1,296,536 CpG sites) was examined by using 
multidimensional scaling analysis (NMDS) (Figure 42). As for the transcriptome analysis, 
samples separated according to the developmental stage (Figure 42) and the methylation 
level increased with time (Figure 43), indicating a strong effect of postnatal development 
on DNA methylation. However, in contrast to the transcriptome, the microbiota did not 
affect the global methylation pattern. By comparing the methylome of CONV-R and GF in 
each time point, we identified 1499, 137 and 220 differently methylation positions (DMPs, 
false discovery rate <0.05) in W1, W4 and W12/16 respectively (Figure 44A). Surprisingly, 
the number of DMPs from the early stage was about 10x higher that of the later stages 
indicating that the microbiota acted stronger on DNA methylation during W1. The detected 
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DMPs were equally hypo- and hypermethylated (Figure 44B). The DMPs were classified 
according to their genomic location: exon, intron, intergenic or promoter. Notably, in W1 
DMPs located in gene promoter regions (within 1500 base pairs upstream and 
downstream of transcription starting sites) were enriched (175 DMPs or 11.67%) 
compared to W4 (1 DMP or 0.73%) and W12/16 (15 DMPs or 6.81%) (Figure 45). 
 
 
Figure 42 Multidimensional scaling analysis plot  
MDS displaying the overall methylation profiles. The developmental factor pattern can be 
recognized in MDS plot, in contrast, bacterial effect is not visible.  
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Figure 43 Overall methylation level across all samples 
The median methylation level was calculated in detected sites. The methylation levels 
generally increase along with the time, regardless of GF or CONV-R. 
 
 
 
Figure 44 Differentially methylated positions 
(A) Venn plot of DMPs in three time points. (B) Hypomethylated and hypermethylated number 
of DMPs in three time points. The number of DMPs in W1 is 10 times higher than W4 an 
W12/16.    
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Figure 45 DMPs location 
DMPs in promoter were enriched in W1, compared to W4 and W12/16.  
 
Gene expression of methylation related gene 
Given the observation of methylation, the gene expression value of some known genes 
which can alter the DNA methylation were further checked (DNA methyltransferase 1: 
DNMT1; DNA methyltransferase 3A: DNMT3a; DNA methyltransferase 3B: DNMT3b; Tet 
methylcytosine dioxygenase 1: TET1; Tet methylcytosine dioxygenase 2: TET2; Tet 
methylcytosine dioxygenase 3: TET3; Ubiquitin Like With PHD And Ring Finger Domains 
1: UHRF1; Ubiquitin Like With PHD And Ring Finger Domains 2: UHRF2; Methyl-CpG 
Binding Domain Protein 2: MBD2; Methyl-CpG Binding Domain Protein 3: MBD3; 
Forkhead box O3: FOXO3 in Figure 46). Expression of DNMt3a and TET3 were highlight 
as significantly altered by the microbiota in W1 and W12/16. DNMT3A is important for de 
novo methylation142, whereas TET3 is essential for demethylation143.  
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Figure 46  Gene expression value for methylation related genes 
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Figure 47 Methylation level of selected methylation sites 
 
As for the transcriptome analysis, all DMPs were ranked based on their p-value and the 
most significant microbiota or developmentally regulated DMPs were chosen for each 
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comparison to generate heatmaps by hierarchical clustering (Figure 47). For the 
microbiota related DMPs, samples clustered according to microbial status and 
developmental stage (Figure 47A) except for few samples with too many missing values 
due to insufficient sequencing depth. For the developmentally related DMPs, samples 
clustered only by developmental stage but not according to microbial status (Figure 47B).  
 
3.2.6  Whole genomic map 
The hierarchical testing approach125 was employed to identify interactions between the 
microbiota dependent alterations in the transcriptome and DNA methylation signatures 
(Figure 15). To that end, all differentially expressed genes (CONV-R vs. GF) for differential 
methylation positions (DMPs) within a 5kb window up- and downstream were screened. 
There were 17, 34 and 79 microbially regulated genes with both an altered expression 
and a differential methylation in W1, W4 and W12/16 respectively (Figure 48). Fry 
(FRY Microtubule Binding Protein) occurred both in W1 and W4, while Cd59a (CD59 
Antigen), Sorcs3 (Sortilin Related VPS10 Domain Containing Receptor 3) and Pik3c3 
(Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3) were reported both in W4 and 
W12/16 (Figure 48). Tracking both the transcriptome and DNA methylation during 
postnatal development allowed us to identify specific changes in the DNA methylation 
signature that may underlie the microbiota dependent transcriptome alterations. For 
example, expression of Camk2b (calcium/calmodulin-dependent protein kinase II), which 
is involved in calcium-dependent signaling144, was only altered by the microbiota at 
W12/16 but not at the younger stages W1 or W4 (Figure 49A). Interestingly, nearby CpG 
sites were not differential methylated at W1, whereas in week W4 we detected three DMPs 
and another four DMPs at W12/16 (Figure 49A). Therefore, either the complete 
demethylation of all DMPs or only the four downstream DMPs may be required to mediate 
the microbial induction of Camk2b expression at W12/16. Another example is Neurl1b, 
expression of Neurl1b (Neuralized E3 Ubiquitin Protein Ligase 1B) which highly expressed 
during embryonic development of the brain and several non-neural tissues145, 
downregulated in CONV-R by the microbiota at W12/16, and the nearby DMPs were 
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hypomethylated only at same time periods. Thus, these four DMPs might also essential 
for microbial induction of Neurl1b (Figure 49B). 
 
 
 
Figure 48 Genes with DMPs in 5kb window. 
Potentially methylation moderiated genes in three 
different stage (hierarchical testing, adjust p-value 
< 0.05) 
 
 
Figure 49 Gene expression and DNA methylation change  
The gene expression and methylation change along with time points in four different genes. 
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The regional plots showed the DMPs and differently gene expression for Pik3c3 in W4 
(Figure 50). The DMPs in Pik3c3 were hypomethylated (CONV-R < GF) in promoter 
region and upregulated (CONV-R > GF) in gene expression. Genome-wide mapping of 
the host-microbiota interactions for gene expression and DNA methylation during the 
three development stages revealed equal distribution among chromosomes (Figure 51). 
Genes belonged to W12/16 highlighted the GO biological process categories, such as 
regulation of multicellular organismal development, positive regulation of multicellular 
organismal process (Table 10).  
 
 
Figure 50 Regional Plot of Pik3c3 in W4 
DMPs in promoter region showed the hypormethylation in CONV-R methylation level and up-
regulated in gene expression. This might potentially point out the relationship between 
methylation and gene expression in Pik3c3 
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W1 
GO term Description P-value FDR q-value 
GO:0043576 regulation of respiratory gaseous exchange 0.000212 1 
GO:0090311 regulation of protein deacetylation 0.000631 1 
    
W4 
GO term Description P-value FDR q-value 
GO:0043271 negative regulation of ion transport 0.0000765 1 
GO:0051051 negative regulation of transport 0.000251 1 
GO:0002294 CD4-positive, alpha-beta T cell differentiation involved in 
immune response 
0.000595 1 
GO:0042093 T-helper cell differentiation 0.000595 1 
GO:0002293 alpha-beta T cell differentiation involved in immune 
response 
0.000737 1 
GO:0002287 alpha-beta T cell activation involved in immune response 0.000814 1 
GO:0021533 cell differentiation in hindbrain 0.000894 1 
    
W12 
GO term Description P-value FDR q-value 
GO:0052697 xenobiotic glucuronidation 3.90E-06 5.57E-02 
GO:0045074 regulation of interleukin-10 biosynthetic process 1.02E-04 7.31E-01 
GO:0052696 flavonoid glucuronidation 1.05E-04 4.98E-01 
GO:0052695 cellular glucuronidation 1.05E-04 3.74E-01 
GO:0009813 flavonoid biosynthetic process 1.05E-04 2.99E-01 
GO:0043412 macromolecule modification 1.15E-04 2.74E-01 
GO:0006063 uronic acid metabolic process 1.27E-04 2.58E-01 
GO:0019585 glucuronate metabolic process 1.27E-04 2.26E-01 
GO:0009812 flavonoid metabolic process 1.51E-04 2.40E-01 
GO:0032879 regulation of localization 2.36E-04 3.37E-01 
GO:0006464 cellular protein modification process 3.53E-04 4.58E-01 
GO:0036211 protein modification process 3.53E-04 4.20E-01 
GO:0042036 negative regulation of cytokine biosynthetic process 4.14E-04 4.54E-01 
GO:0016569 covalent chromatin modification 4.57E-04 4.66E-01 
GO:0050864 regulation of B cell activation 4.58E-04 4.36E-01 
GO:0001782 B cell homeostasis 5.22E-04 4.66E-01 
GO:0006325 chromatin organization 5.38E-04 4.52E-01 
GO:0051239 regulation of multicellular organismal process 6.67E-04 5.29E-01 
GO:0050869 negative regulation of B cell activation 7.15E-04 5.37E-01 
 
Table 10 GO analysis for DE-DM gene 
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Figure 51 Genomic map of all methylation-transcription interactions 
Genomic map of all methylation-transcription interactions dependent on the microbiota and 
postnatal development. The boxes in the outer circle depict the mouse chromosomes. The boxes 
in the inner circle represent genes that were both differentially expressed and methylated. The 
gene name is colored according to the expression difference in CONV-R vs. GF comparison (red 
= up-regulated, blue = down-regulated). Box coloring corresponds to the developmental stage, 
in which a significant difference was detected (red = W1, green = W4, blue = W12/16). Length 
of the boxes indicate the methylation difference in CONV-R vs. GF comparison. Red and blue 
dots within the gene boxes represent hyper- and hypomethylated CpG sites respectively. 
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4.  Discussion 
4.1  Cross-talk of transcriptome, epigenome and 
microbiota in intestinal inflammation 
This study mainly aims for understanding the interaction between three omics layer in UC: 
transcriptome, epigenome and gut microbiota. Monozygotic (MZ) discordant twins were 
recruited in this study. The identical genes in twin subjects contribute equally genetic effect 
in UC. Thus, the setting of this experiment can farther investigate the other disease factors 
apart of genetic. Besides the shared genes, the twin subjects might also be raised in the 
same home, and experienced equally similar environments in their earlier life. One might 
argue that shared environment assumption might not be hold exactly, however, some 
researches suggest that parents, teachers, peers and others may treat identical twins 
more similarly than fraternal twins146.  Based on this design,  this study can focus on the 
risk contribution of non-shared environment, which are the epigenetic marker and 
epigenetic-microbiota interaction in this case.   
4.1.1  Microbiota status in intestinal inflammation 
In this study, kinship and disease effect were observed as the determining factors for the 
gut microbiota composition. First, Shannon entropy difference between the twin pairs 
increases along with the age (Figure 17). Twin pairs were raised in the same environment 
during their early life, thus the microbiota compositions pattern were very similar in the 
early age. This dissimilarity of the microbiota composition increases because the change 
of life style and surrounding areas. This reflects the importance of environment factor on 
microbiota. In the best of my knowledge, this finding have not been reported in other 
discordant MZ studies. One might further investigate the non-shared environment with 
more information in MZ study, such as household or smoking. Furthermore, the coming 
study can also look deeper in to bacterial taxonomy, the variety of specific bacteria phylum 
or genus might link to metabolic function for intestine inflammation.  
Surprisingly, the kinship effect was still visible in microbiota composition, even in the elder 
twin pairs (Figure 19). Inter-individual distances between unrelated subjects were higher 
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than the distances between pairs. To note, one sibling was disease and the other was 
healthy, thus we can claim that the kinship effect exist in disease scenario. My finding in 
this study was also reported similarly in previous studies. One Chinese study showed that 
the microbiota composition in infant MZ is similar than dizygotic (DZ) twin or non-twins.147 
They also mentioned the age represent the strong factor to shape the microbiota 
composition, even before one year of age. Furthermore, the connection of microbiota 
composition and age has also been reported in adult twins. Dicksved, J. et al. found the 
microbiota composition in CD MZ discordant twin pairs is less similar than the healthy 
twins and CD concordant MZ twins148. However, the dizygotic healthy twin pairs were very 
young (7–8 years old), and were still living in the same household. This could also 
contribute to their high similarities in profiles apart of genetic effect. In conclusion, there is 
a clear association between microbiota and kinship.     
Furthermore, disease status was also associated tightly with dysbiosis. In Figure 18, the 
diversity differences between UC and healthy were visible and lower in UC compared to 
healthy partners. The study from Lepage et al149 mentioned that the bacterial abundance 
of Bacteroidetes and Firmicutes in unaffected siblings from UC discordant pairs is even 
closer to healthy individual than the affected siblings. Furthermore, this pattern was also 
observed in CD twins. CD patients with ileal involvement clustered separately from all 
others148. All these consistent studies confirmed the association with dysbiosis and 
intestine inflammation.  
  
4.1.2  Epigenome-transcriptome interaction in ulcerative colitis 
This study followed the study from Haesler et al49, but only focused on the genes with 
specific immune or defense related function. The aim of this study was to detect the 
epigenetic linked immune-related genes as well as microbiota change in UC. Obviously, 
this approach cannot demonstrate the causality of epigenome-transcriptome interaction. 
Even though, this targeted disease-associated transcripts might support the hypothesis 
that pathophysiological events are a reflection of—and potentially controlled by—
epigenetic modifications with consequences on transcriptional changes. 15 genes were 
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differentially expressed between UC and healthy control and highly correlated with the 
adjacent CpG sites. These genes were considered as epigenetic-related genes for UC. 
Furthermore, the gene expression of eight genes (ISG20, LYN, AGT, CFB, S100A8, 
OAS1, TNFSF10 and CCL11) were then confirmed differentially expressed in unrelated 
UC and healthy cohort in the validation cohort. These eight genes directly link to regulation 
of inflammatory response (GO analysis, p-value=9.85E-5). This is consistent with previous 
findings on functional genomics of UC44. The consistency potentially attributes to the lower 
technical and/or biological variance in inflammation-associated mRNA patterns.  
By all of these findings, certain genes have been directly/indirectly associated with chronic 
intestinal inflammation or gut microbiota; ISG20 (Interferon Stimulated Exonuclease Gene 
20) and OAS1 (2'-5'-Oligoadenylate Synthetase 1) are related to Immune response IFN 
alpha/beta signaling pathway. OAS1 and the other IFN pathway related genes were found 
increased from ileum in indoor-housed piglets compared to outdoor-housed piglets, 
indicating that the IFNα/β pathway is directly affected by the housing environment150. They 
further suggested that microbial composition influences Type 1 IFN signaling during early 
colonization and development. TNFSF10 (Tumor Necrosis Factor Superfamily Member 
10) has been identified as IBD associated gene, it disrupts the intestinal epithelium 
integrity by induction of epithelial cells apoptosis and possible contribution to development 
of fistulas and strictures in CD patients151. CCL11 ( C-C Motif Chemokine Ligand 11) which 
is a eosinophil-specific chemokine gene has been associated with IBD pathogenesis152. 
Waddell et al suggested that Ly6ChighCCR2+ inflammatory monocyte/macrophage-derived 
CCL11 mediated DSS-induced colonic eosinophilia153. 
UC-relevant epigenetic modifications as well as their interaction with environmental 
factors was first reported in 1996 by Gloria et al154. Environmental factor regulated 
epigenetic markers have been reported as a contributor to disease susceptibility, 
manifestation, and progression155. There are around 100 genes whose methylation have 
been related UC156 in previous studies. A recent methylome study of UC patients reported 
three genes (FAM217B, KIAA1614 and RIBC2) were found to be significantly enhancing 
the promoter methylation levels if compared to normal controls157. In this study, 15 genes 
were found with strong association between methylation and transcription. Three (AGT, 
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TNFSF10, CFB) genes then further validated as epigenetic related in independent cohort. 
The methylation level in the promoter region of TNFSF10 (cg number: cg11979312) 
showed differentially methylated pattern between UC patients and healthy control, and 
furthermore associated with gene expression of TNFSF10. TNFSF10 is also reported as 
epigenetic marker in the previous intestine inflammation study. The methylation level in 
the gene body of TNFSF10 (cg number: cg01059398) is able to discriminate between 
disease and control in UC60 accurately.  
Conclusively, the variation of the outcome in different studies are likely from the sample 
collected location, different cell/tissue and technical process. Although there are amount 
of evidence supporting the role of DNA methylation in regulating gene transcription, 
however, the functional relation within these gene has not been fully revealed. 
Determining the causative relationship between an epigenetic marker and gene 
expression is one of the major challenges in the IBD study. Furthermore, this finding might 
be limited by the microarray design; HM27 array which obviously cannot cover all the 
regions around the targeted genes. One might use the up-to-date EPIC or NGS for further 
research. 
 
4.1.3  Transcriptome-microbiome interaction in ulcerative 
colitis 
The commensal microbiota is well known for shaping the immune system and is involved 
in many host physiological functions including the digestion of nutrients. Furthermore, the 
transcriptional changes associated with IBD has been shown in different studies. However, 
only few studies have addressed the connection between the human mucosal 
transcriptome and the gut microbiota158,159. For the best of my knowledge, this study is the 
first to correlate the gut microbiota and epigenetic linked transcripts in UC patients. There 
were 17 bacterial OTUs identified with the strong correlation between the epigenetic 
markers and transcripts in twins cohort. Furthermore, two (Clostridium_XlVa and 
Bacteroides) were validated in the independent cohort. This finding suggests the presence 
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of these bacteria might be due to a defect in the barrier function of the epithelium in UC 
and potentially acted as the environment factor for modulating epigenetic marker. 
Clostridium cluster XIVa, butyrate-producing species, specifically colonize mucins in gut 
model160. Clostridium cluster XIVa were enriched in the mucosal environment, and the 
butyrate-producing bacteria from these clusters had higher abundances in the luminal 
content. Butyrate is a short chain fatty acid (SCFA) derived from the microbial fermentation 
of dietary fibers in the colon161. One study suggests that probiotics induced epigenetic 
mechanisms through butyrate162. In another study, butyrate is also able to modulate 
intestinal microflora through regulation of lumen pH and to exert many beneficial 
extraintestinal effects through epigenetic mechanisms163. In a review paper from Canani 
et al164, they made the connection between diet and epigenetic modulation through 
butyrate and listed the effect for some complex disease (Figure 52). Deeper study of 
butyrate might help to develop improved strategies for regenerative medicine by 
promoting epigenetic remodeling and the expression of pluripotency-associated genes. In 
this context, discovery of mucosal butyrate producers may lead to a novel therapy for IBD, 
which are characterized by an impaired butyrate transport to the colonocytes. Gever et al 
investigated the gut microbiota composition from 447 children and adolescents (< 17 
years) with newly diagnosed CD. They investigated samples from multiple gastrointestinal 
locations collected both prior and after antibiotic treatment. The increased levels of 
Bacteroides and Clostridiales were found in patients who are non-CD afterwards 
compared to those who maintain in CD165. Consistently, the increase of Bacteroides 
abundance in healthy controls also found in the discordant MZ UC twins cohort as well as 
in the validation panel. 
In conclusion, this human twin pairs study provides us the unique opportunity to 
discriminate between the contribution of genetic and environmental factors to phenotypic 
variance. One might keep following the finding for more biological functional analysis, and 
discover the direct/indirect functional host-microbiome interaction in intestine inflammation.    
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Figure 52 Diet influences intestinal microbiota  
Diet influences intestinal microbiota composition. The balance of intestinal microbiota has an 
important role in the fermentation of dietary. Butyrate exerts multiple beneficial effects at 
intestinal and extraintestinal level, linked to the epigenetic regulation of gene expression. Figure 
is modified from Canani et al164 
 
 
4.2  Cross-talk of transcriptome, epigenome and 
microbiome in intestinal development 
This study systematically investigated the regulatory effects of the microbiota on the 
transcriptome and the genome-wide DNA methylation status of IECs from the small 
intestine of infant, juvenile and adult mice, which were raised either in the presence or in 
absence of a microbiota. This analysis revealed that both the IEC ontogeny and the 
microbiota affect the epithelial transcriptome signature along with the DNA methylation 
status and that the microbial effect increases during postnatal development. Furthermore, 
the microbial impact on the interplay of DNA methylation and the epithelial transcriptome 
were stage-specific as we detected almost no overlap between the genes that were 
regulated by the microbiota and also displayed an altered DNA methylation status for the 
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three developmental stages. Our data provide groundwork to dissect the endogenous 
developmental and microbial effects on the host’s transcriptional and epigenetic program 
on a mechanistic level. 
 
4.2.1  Dynamic transcriptome and epigenome pattern during 
development  
This study validated that many developmentally regulated genes such as Pigr (polymeric 
immunoglobulin receptor), which was reported to have an increasing expression from 
infant to juvenile or Tet1 (Ten-eleven translocation methylcytosine dioxygenase 1) having 
a decreasing expression from infant to juvenile166, in addition also were differentially 
methylated and therefore appeared to be epigenetically regulated during postnatal 
development. Moreover, several genes were previously reported as microbially regulated 
in the adult19,167, and were also regulated transcriptionally during postnatal development. 
For example, the glycolysis regulator Pfkfb3 (6-phosphofructo-2-kinase) was not only 
induced by the microbiota in the adult as reported19,167, but is already microbially regulated 
in the infant. 
Surprisingly, about ten times more DMPs in W1 were detected compared to W4 or W12/16. 
Since methylation levels did not differ between the developmental stages, the increased 
number of DMPs in W1 did not seem to be simply due to higher overall methylation activity. 
Instead, the microbiota may differentially modulate de novo methylation and 
demethylation in the neonate mice. First, I detected generally higher levels of Dnmt3a 
(DNA-methyltransferase 3A) during W1 compared to W4 or W12/16 and increased 
expression in CONV-R compared to GF mice. As DNMT3 (DNA-methyltransferase 3) 
mediates de novo methylation and parental imprinting168, this temporal and microbiota 
dependent expression pattern of Dnmt3a may therefore relate to the increased number of 
hypermethylated DMPs in the newborn mice. Conversely, Tet3 expression was induced 
by the microbiota in W1 and since TET3 possesses hydroxymethylation activity169,170 and 
therefore mediates demethylation143, the time- and microbiota-dependent expression 
pattern of Tet3 may thus contribute to the increasing number of hypomethylated DMPs 
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with increasing age. However, the maternal imprinting effect can not be rule out, which 
may be dependent on the presence of microbiota in the mother before birth.  
 
4.2.2  Microbiota modified epigenome-transcriptome 
interaction in intestinal development 
The value of this experimental approach is demonstrated by the finding that although 
several previous studies established that the microbiota modulates the expression of more 
than 2,000 genes in the intestinal epithelium19,167,171 , only a subset of these microbiota-
responsive genes appear to be regulated by the epigenetic process of DNA methylation. 
Using this approach, the microbiota was found to inversely affect DNA methylation and 
gene expression throughout postnatal development. Whereas the number of differentially 
expressed (CONV-R vs. GF) genes increased with postnatal development, the number of 
DMPs decreased from W1 to W12/16. The number of genes that are regulated by the 
microbiota both in their transcription and DNA methylation (differentially expressed and 
DMPs within 5kb window) increased with time. Together these observations indicate that 
the microbial effect on modifying the epithelial DNA methylation and transcriptional status 
increased during maturation and postnatal development of the intestine. However, the 
microbiota did not seem to engage DNA methylation to regulate transcriptional responses 
globally, but instead only seemed to target a specific subset of microbially responsive 
genes through their DNA methylation status. This unexpected finding is not caused by 
inherent differences in this and published datasets as, for example, our transcriptome 
sequencing data and the list of microbially regulated genes from the adult stage 
overlapped significantly with our previous data obtained from microarray analysis of laser-
dissected ileal IECs19. This observations are further supported by a study by Camp et al., 
which reported that the microbiota did not globally alter the chromatin architecture to drive 
gene expression but only for specific genes21. Thus, host epigenetic mechanisms do not 
seem to be employed by the gut microbiota to drive transcriptional responses on a global 
scale.  
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Future studies are needed to functionally validate the involvement of methylation 
modifying enzymes during early postnatal development and in relation to the microbiota. 
For example, tracking the changes in intestinal microbiota composition along with 
epithelial DNA methylation and transcriptome signatures of DNMT or TET-deficient mice 
during postnatal development would be a promising approach. Together our data 
suggests that the microbiota seems to engage components of the DNA methylation 
machinery, which may at least partially translate into the observed epigenetic and 
transcriptional differences through postnatal development. 
 
4.3  Methodological considerations and pitfalls 
The genomic scale data from this study are based on microarray and NGS technologies. 
With the application of these technologies, a higher resolution for epigenome and 
transcriptome status of a cell can be obtained. With the evolution and advancement of 
technologies, enormous amounts of data has been generated. How to manage and use 
the proper statistical method to get meaningful results remains an issue and challenge. In 
this context, the pros and cons of microarray and NGS with regards to statistics and data 
processing will be discussed 
 
4.3.1  Improvement of genome-wide screening technique  
The concept and methodology of microarrays was first introduced by Tse Wen Chang in 
1983172, and commercialize in 1995173. The invention of microarray opened new field in 
genomic research. Microarrays have been applied in various fields of biology (e.g. gene 
expression, genotyping and DNA methylation) and have yielded numerous significant 
findings in clinical and basic research. However, arrays suffer from their fundamental “pre-
select” design. With the radical decline in sequencing costs and the greater improvements 
in NGS systems, a large number of studies are now performed using NGS. Both 
microarray and NGS techniques were performed in this study to analyze transcriptome 
and methylome. The processed twins study data  was generated in 2009 using  microarray 
as it was the popular whole genome screening technique in that era. Even NGS already 
93 
 
existed in 2009, but the price was higher, and accuracy was not well established and 
accepted in scientific community. In the second mouse study, all data were generated in 
2014, the protocol of library preparation and analysis pipeline for NGS are all well built up 
in-house. Therefore, NGS methodology was employed for mouse study. 
 
Transcriptome 
There are several obvious benefits to encourage the researcher switching from microarray 
to RNA-Seq in gene expression detection. The most important reason is that RNA-Seq 
does not require any prior knowledge the species and genes under investigation. 
Furthermore, RNA-Seq allows the detection theoretically in whole transcriptome and 
analyses of novel transcripts, splice junctions and noncoding RNAs as well. These 
characteristic of RNA-Seq can identify the novel associated genes which are not included 
in microarray. Microarray was employed in the twins study and RNA-Seq was used in 
mouse study. There is a significant difference of discovered gene numbers between two 
studies. 11544 expressed genes were found in twins study while almost double gene 
numbers (21619 genes) were detected in mouse study by using RNA-Seq. This unbiased 
feature allows researchers to have broad view for the gene expression modification.  
 
Methylome 
HumanMethylation27K BeadChip (HM27) for whole methylome was used in twins study. 
It claims to contain 25,578 probes predominantly targeting CpG sites within the proximal 
promoter region of 14,475 consensus coding sequence (CCDS) genes174. However, after 
quality control, only 23,477 methylation sites were remained available for analysis. 
Obviously, HM27 cannot cover whole methylome, thus the company developed new 
microarray Infinium HumanMethylation450 BeadChip (HM450) in 2011 and Infinium 
MethylationEPIC (EPIC) BeadChip in 2015, which can detect over 485,000 and over 
850,000 methylation sites per sample at single-nucleotide resolution, respectively. HM450 
and EPIC are still the popular tools for EWAS studies, and widely embraces by the 
epigenetics research community. However, there is no well-developed mouse genome-
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wide DNA methylation array equivalent to the human methylation array. Dr. Richard 
Saffery’s group from the University of Melbourne got a creative idea to use human DNA 
methylation arrays on mouse samples175. Their idea was proven and the measurements 
were replicated by a different assay. Even though, only 13,715 uniquely mapping probes 
in bisulfite space of mm9 were found on the HM450. After comparing the price and the 
amount of information, NGS for methylome study was chosen in the mouse study. In this 
study, 1,296,536 methylation positions were discovered by RRBS. The number of 
methylation site is 55 times than in twins study.  
Two popular NGS methods, WGBS and RRBS, are already mentioned in 1.7.3 . In best 
of my knowledge, RRBS provides the best cost-benefit trade-off compared to WGBS, 
which yields 50-fold  more  reads  per  sample  and  is  therefore  comparatively  more  
expensive  and computationally intensive. For the following, one might use oxidative 
RRBS which can distingue hydroxyl-methylation and methylation within the sample. It 
reveals a complete picture of genomic state of methylation, and provides the board view 
of the function of hydroxyl-methylation. 
 
4.3.2  Statistical and bioinformatics concern in genome data 
science  
With the rapid improvement of whole genome screening technique, the enormous amount 
of genomic data have been generated in past decade. However, processing and analysis 
the various type of large dataset in different biological layer is a bottleneck. In this 
paragraph, the statistical and bioinformatics approach that were employed in this thesis 
will be discussed.  
 
Microarray 
Nowadays, microarray has been considered as an out-of-date method, especially for 
transcriptome studies. However, there are two main reasons for researcher to continue 
choosing microarray for transcriptome study: price and easy bioinformatics analysis 
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process. Take the transcriptome analysis as the example, the price of Illumina NextSeq 
500 NGS is around 5 to 10 times than Affymetrix GeneChips in different experiment 
setting176. The researcher might choose microarray under the limit budget. For the 
analysis, Affymetrix provides its own software for data pre-processing. Herein researcher 
can easily click the button for choosing different filter criteria. Besides, one can also use 
well-established bioinformatics and statistics practices with free software packages that 
can almost do everything for people not familiar with computational work. The downside 
of array is that it can only be applied in organism with good reference sequence (e.g. 
human). It is useless for researcher who are interested in organism whose genome is 
either not sequenced or little information is available about their genetic components. 
In contrast to the downside of microarray in transcriptome, microarray in DNA methylation 
is still active in recent research. HM450 covers methylation positions in a good degree 
and the newest EPIC chips can even cover 850K methylation sites. Even one can argue 
the selecting bias for coding and promoter regions, arrays still provide a good initial 
overview for methylation study. My research group benefited from the light computation 
work of HM27 in twins study which give us a good start point. For the following study, one 
could continue with deeper insight in to methylation pattern by using EPIC or NGS. 
Regarding to the analysis tool, Rnbeads119 is an all-inclusive package for data quality 
check and statistical analysis. It is initially designed for microarray, and then further 
supports the entire high-throughput methylation platform (e.g. HM27, HM450 and EPIC). 
It generates a lot of presentable figures and the reliable statistical results for microarray.  
 
RNA-Seq 
After data preprocessing, RNA-Seq provides the number of reads that map to each 
transcript sequence. The higher coverage across genes is a statistical advantage. 
However, it biased towards transcript length i.e. longer transcripts or genes will  have more 
reads mapped to it compared to shorter ones power177. According to this matter, many 
studies employ FPKM178 (fragments per kilobase per million mapped reads) for paired-
end reads RNA-Seq or RPKM178 (reads per kilobase per million mapped reads) for single-
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end reads RNA-Seq as the quantitative measurements. For calculating the RPKM value, 
the row reads were first divided by 1,000,000 and then normalized for sequencing depth 
in each sample to get reads per million (RPM). Then the RPM values were divided by the 
length of the gene in kilobases to get RPKM. Comparably, the calculation of FPKM is very 
similar to RPKM, the only difference is that FPKM takes into account that two reads can 
map to one fragment. FPKM and RPKM can be generated by Cufflink179 and serve as an 
input to Cuffdiff2180 for differential expression. However, this approach changes the  data  
variance  according  to  the gene length normalization and adds to a new source of bias177. 
For this study, the reads were only normalized by the sequencing depth. The focus of the 
differentially expression comparisons in this study is on the difference between biological 
conditions in same gene, not the difference between genes. Thus, the gene length 
normalization is not necessary for this study. 
Unlike the intensity measurement from microarray, RNA-Seq generates discrete count 
data. The general statistical approaches like student t-test or Wilcoxon non-parametric 
test might not be the proper methods for differentially expression detection in RNA-Seq. 
These methods are too conservative so that the biological signals couldn’t be found 
because of the small sample size and the measurement noise. Thus, negative binomial 
model181, poisson model180 and other non-parametric approaches182 have been 
introduced to fit RNA-Seq data distribution for differentially expression analysis. For the 
current study, the differential expression gene calculation was done using DESeq2. It 
assumes that the count data follows the negative binomial distribution, and uses 
generalized linear model to find the significant expressed genes. DESeq2 is chosen due 
to the low FDR and lower computational requirements compared to other methods183. One 
should always select the proper method based on data heterogeneity, sample size, 
experimental setting and the computational loading. Suitable statistical models would help 
in making either the right conclusions or achieving results that might be used to generate 
new hypothesis for testing them in functional experiments.   
 
RRBS 
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In order to achieve the right statistics and coverage of CpG sites, I modified several 
computational parameters starting from preprocessing until the downstream analysis in 
RRBS data. RnBeads helps me to handle memory issues efficiently and accounts for 
many covariates. It provides me a good overview and descriptive statistic of data quality. 
However, the differential methylation site analysis in Rnbeads is based on R package 
LIMMA184 (Linear Models for Microarray Data) which is designed for gene expression 
microarray data. For the statistical point of view, RRBS data does not fit this model 
assumption. The processed RRBS data gives the number of methylated C and un-
methylated C. The proportion of unchanged Cs regarded as the absolute DNA methylation 
level. The proportion usually follows the bimodal distribution instead of normally 
distributed data assumption. Additionally, methylation data is limited within the range of 0 
and 1, and therefore variability is much smaller at the extreme values. Thus, another tool 
instead of RnBeads was chosen for differently methylation site detection. 
There are several common ways to analysis methylation data DMP (differentially 
methylated positions) and DMR (differentially methylated regions). In this regard, 
Bayesian-Beta binominal model seems to be the best-fit model for DMP and DMR 
detection. Many methods are built by this assumption, like Biseq125, MOABS185 and 
DSS110, usually, the strong effect is not sensitive to these chosen method. DSS 
(Dispersion shrinakge for sequencing data) was chosen because of the user-friendly 
interface and the character for processing the sparse data like RRBS. Any statistical 
method that tests for millions of CpGs needs to face the multiple correction issues to avoid 
many false positives results. Only the strongest single-CpG site differences would remain 
significant after correction for multiple testing. However, this conservative strategy might 
ignore the biological effect with less strong signal. In order to, not to over-correct the 
multiple testing, hierarchal testing approach (2.2.6 ) was applied in this study to identify 
the methylation signals.  
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4.4  Outlook for clinical applications in intestinal 
inflammation 
4.4.1  Detection of Biomarkers for diagnosis or monitoring of 
IBD  
Biomarker in medicine refers to the measurable physical, functional, biochemical 
indicators of which can identify the physiological changes, or disease processes. Several 
biological measurements have been identified as biomarkers of IBD186. C-reactive protein 
(CRP) is produced by hepatocytes in response to inflammation, stimulated by certain 
cytokines. CRP levels increase significantly during IBD, but the rise of CRP might also be 
due to infection, autoimmune conditions, other inflammatory conditions, and malignancy 
as well as cell necrosis187. Erythrocyte sedimentation rate (ESR) is another biomarker for 
IBD188. ESR is an indirect measurement of plasma acute phase protein concentration. 
Like CRP, ESR is a generally detection index of systemic inflammation, not entirely 
specific to IBD. The correlation between ESR and UC is good, but less accurate with CD. 
Certainly, genetic variants are also important biomarkers in IBD. With the rapid 
improvement of sequencing techniques, a number of genome-wide association study 
(GWAS) has discovered susceptibility genetic locies in IBD. PRDM1 (PR domain zinc 
finger protein 1) and NDP52 (Nuclear Domain 10 Protein 52) were determined to increase 
susceptibility to CD189. A latest study from the Wellcome Trust Sanger Institute and their 
collaborators have identified the genetic variant of ADCY7 (Adenylate Cyclase 7) that 
doubles an individual's risk of developing UC190.  
Changes in gut microbiota profiles and methylation patterns also strongly associated with 
IBD. Both changes are considered as the potential important biomarkers for the disease. 
Hypermethylation in several gene promoter regions including APC (Adenomatous 
polyposis coli), TIMP3 (Tissue Inhibitor Of Metalloproteinases 3) were found aberrant in 
IBD-related colorectal cancer (CRC) patients191. Moreover, Carmona and colleague 
discovered the increase methylation pattern in several genes in tumor samples compared 
to normal tissue from CRC patient biopsies. Three of their findings (AGTR1: Angiotensin 
II Receptor Type 1, WNT2: Wnt Family Member 2 and SLIT2: Slit Guidance Ligand 2 ) 
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were validated in stool DNA with same hypermethylation pattern of affected CRC patients 
(with a detection sensitivity of 78%)192. A review paper from Karatza et al listed the 
suspicious methylation position and related genes as potential biomarkers in IBD156. 
Among all the biomarker in previous studies, the methylation site around TNFSF10 which 
can discriminate between disease and control in UC was found both from Ventham et al 
60 and this twins study. TNFSF10 has been shown to be subject to methylation-dependent 
silencing in cancer cells193 and might serve as an UC-detection biomarker in the future. 
To summarize, the methylation status in these candidate genes from stool or tissues can 
serve as biomarkers to intestinal inflammation diagnose. 
Comparable to epigenetic signatures, dysbiosis of microbiota in IBD can also serve as a 
clinical biomarker. In a pediatric IBD study, researcher used anti-TNF therapy which 
increased relative abundance of Gram-positive bacteria (especially Clostridium clusters 
IV and XIVa). These bacteria were found associated with patients responding to anti-TNF 
therapy194. Interestingly, Clostridium clusters XIVa was identified in my twin study and 
showed strong correlation with methylation modulated genes (Section 3.1.4 ). Hence, the 
change of Clostridium clusters XIVa aboudance might be a potential index for IBD 
diagnose. Furthermore, the decrease of Faecalibacterium prausnitzii population in the 
resected ileum correlated with increased risk of recurrence from a post-operative 
recurrence cohort in CD195. The information of the change in candidate bacteria 
abundance can be extracted very easily from stool sample in routine health check. 
Especially for the people with IBD family history, this non-invasive test can monitor the 
potential disease status progress. 
Although more and more biological signals from omics studies (microbiome, 
epigenome…etc) have been identified as statistically different in intestine inflammation 
scenario, only few of them are useful for clinical application in IBD practice196. One reason 
is the inconsistent of population stratification and patient materials between researches. 
IBD is a genetic associated disease, the population stratification is very essential. The 
significance of prevalence exists between different populations and contries33. Moreover, 
the collection of patient material is also matter. In IBD studies, some of them had biopsy, 
other groups employed blood sample and another took the stool. This inconsistent might 
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lead to different results, even gene expression pattern differs in different location of 
intestine in the same indiviual19. The biomarkers, which were found differentially between 
healthy control and patients, really depended on the material of sample collection. The 
other reason is the limitation of the experiment design; mainly studies so far were cross-
sectional studies. Researcher aiming for biomarker detection in earlier diagnose of IBD 
should design as prospective study to monitor disease progression in the same individual. 
Because both the gut microbiome and the epigenome are very sensitive to environmental 
factors and the biological variation is huge in every individual. The longitudinal study could 
enhance the reliability for the target groups. With the drop of sequencing price nowadays, 
the study design in the future could be more flexible. 
In conclusion, the results in my study might bring some hints for understanding the 
biological function of IBD and the raise of omics-integrate studies could provide better 
insight of biomarker detection.  
4.4.2  Environmental effects as risk factors in intestinal 
inflammation 
This research focused on host-microbiota interactions in intestinal inflammation and the 
dynamic pattern in during intestine development. Apart from the microbiota, many other 
environmental factors also play a role in intestinal inflammation. These factors not only 
contribute to intestine status individually but also interact with the other factors (Figure 53). 
The interplay between genetics, immunology, environment and microbiome has been 
shown in several studies. IBD develops at the intersection of genetic predisposition 
(leading to immunological abnormalities), dysbiosis of the gut microbiota and 
environmental influences33. Some environmental factors such as diet, have been 
identified as crucial factors for IBD and widely studied. However, there are several factors 
also contributed to IBD have not yet generally investigated. In the following part, the 
impact of other risk factors of IBD including smoking, vitamin D intake and sleeping sleep 
disturbance will be discussed. These factors might potentially become the further research 
direction of IBD.   
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The relationship between smoking and IBD is complex. Smoking seems to have opposite 
effects in UC and CD. Surprisingly, smoking is a risk factor for CD, but protective for UC197. 
There was a Swedish twins follow-up study showing that twin who smoked might develop 
CD whereas the other non-smoking twin might develop UC198. A meta-analysis study 
compared the IBD risk of current smoking and ex-smoking people199. They found that 
current smoking had a protective effect on the development of UC when compared with 
controls. Smoking was shown to affect T cells which express the α7 nicotinic receptor  
causing production of T helper (TH) 1 cytokine interferon-γ which has been associated  
with CD but not to UC200. From the epidemiology point, interestingly, highest adult male 
smokers countries (60-70%) like China and Mongolia with low prevalence of IBD, whereas 
countries like Sweden and Canada with overall high IBD rates have lower percentage of 
male smokers (17-28%)201. Even the smoking has the protective effect for UC statistically, 
one should be aware that the evidence only showed the association not causality. More 
functional study need to be established for verifying the role of smoking in IBD. To 
conclude, smoking as the IBD-related environmental factor is neither necessary nor 
sufficient to cause or protect IBD202. 
Vitamin D insufficiency can be found in up to 60% to 70% of IBD patients203, but because 
of the well-known chicken-or-the-egg–type dilemma it cannot be described as causative 
for the disease outbreak. Nevertheless, vitamin D deficiency is a significant component in 
the development of IBD. The Vitamin D level in the body has strong connection with 
sunlight (ultraviolet B rays) exposure. During exposure to sunlight, 7-dehydrocholesterol 
in the skin absorbs ultraviolet B radiation and then converted to pre-vitamin D3 which in 
turn isomerizes into vitamin D3204. By using national health insurance databases, 
researcher found that high residential sunlight exposure was associated with a significant 
decrease in risk of CD, but not UC205. Vitamin D can be considered as a hormone with a 
number of effects on the immune system that are responsible for mediating susceptibility 
to infections206. Furthermore, one latest GWAS study suggested that the genetic variation 
at Vitamin D receptor (VDR) locus significantly influences microbial co-metabolism and 
the gut–liver axis207. In the future, it might be interesting to perform a mouse colitis 
experiment with DSS mice model in different UV exposure setting to discover the 
direct/indirect effect for IBD and furthermore investigate the change of vitamin D level as 
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well as gut microbiota composition. Further understanding of the relationship between IBD 
and vitamin D might be helpful for developing personalized therapies, e.g. UV exposure.   
Sleep disturbance has also been identified as a risk factor of IBD. Patients with IBD are 
at increased risk for altered sleep patterns208. Shift workers with disrupted sleep pattern 
get higher risk in some gastrointestinal diseases (e.g. gastroesophageal reflux disease209 
and peptic ulcer disease210). Thaiss et al. showed that the diurnal oscillations of intestinal 
microbiota shape leads to time-specific compositional and functional profiles over the 
course of a day in both mice and humans211. Fecal transplantiation of human stool from 
donors with jet lag to mice resulted in glucose intolerance and obesity211. It might be 
interesting to investigate the effect of sleep-disturbance dysbiosis in intestine inflammation. 
One could first design a mouse study with two genotype in two different conditions: wild 
type vs IBD associated knock-out gene (NOD2, ATG16…etc) genotype and normal 
sleeping pattern vs sleeping disturbance. Through this study design, one could observe 
changes of gut microbiota pattern and discover the potential impact on sleeping 
disturbance. The future knowledge of identified pathways in pathophysiology and course 
of IBD may lead to the most appropriate therapies applying in an individual approach. For 
some patients, curing IBD via sleep pattern adjustment might be more efficient than 
invasive medical procedures212 which can prevent the waste of the medical resource and 
reduce the pain of the patient during the treatment. 
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Figure 53 The important factors for IBD development 
None of the risk factors alone are sufficient for the development of the disease and complex 
interactions between each factor occur before IBD break-out. Figure is modified from 
Ananthakrishnan et al33 
 
 
4.5  Conclusion 
With the advantage of omics research, it became clear that most complex diseases such 
as IBD arise not due to a single factor in a single layer. DNA methylation as the non-
genetic medium may influence host gene expression through other environmental factors. 
A dysfunction of gene-environmental interaction in each biological layer might trigger 
intestinal inflammation. Besides, the balance of gut microbiota composition maintains the 
function of the host immune system of the gut. In order to understand and moderate IBD 
development, it is important to study interaction between DNA methylation and gut 
microbiota as well as the interplay with other factors. 
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This thesis mainly identified the DNA methylation marks and the corresponding bacterial 
effect that could contribute to the UC pathophysiology and the dynamic pattern during the 
intestinal maturation. Biological validation of this study is important to confirm the finding 
here and then investigate the pathway for further clinical application.  
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5.  Summary 
The role of epigenetic alterations and the interplay with the intestinal microbiota and 
inflammation is still not fully understood. I herein employed high throughput genomic 
screening technique to investigate the influence of interaction between host transcriptome, 
host epigenome and intestinal microbiota in human and mice. In my first twins study, a 
three-layer epigenome-wide association study (EWAS) is reported, using intestinal 
biopsies from  ten  monozygotic  twin  pairs  discordant  for  the  manifestation of UC by 
employing NGS (16S rRNA gene sequencing) and microarray (HM27 and Affeymetrix 
U133). Furthermore, the finding are validated in independent cohort with UC and healthy 
control (n=20 in two groups). The identified candidate genes have been functionally 
implicated in regulation of inflammatory response, and the identified bacterial genera have 
the potential impact of methylation modification. The targeted genes and bacteria could 
be taken further for technological and biological validation to identify their associations 
with IBD disease etiology and metabolic disorders. 
The second mouse study showed the bacterial effect during intestine maturation process 
in intestinal epithelial cells (IECs) in GF and CONV-R mice in three different development 
stages. RNA-Seq and RRBS were employed for measuring the dynamic pattern of 
transcriptome and methylome. Postnatal development was observed to affect DNA 
methylation signatures and expression in IECs indicating that epigenetic processes 
contribute to developmental transitions largely driven by endogenous programs, 
independent of microbial cues. However, this data clearly shows that the gut microbiota 
influences specific modules of the epithelial transcriptional network during postnatal 
development and targets only a subset of microbially responsive genes mainly functioning 
in IEC proliferation and immune responses through their DNA methylation status. 
To summarize, the results shown here confirms that the host-microbiota interaction is a 
critical check pint for intestinal inflammation and development. Though, it is still a debate 
whether the interaction is a cause or consequence of the disease, the results indicate a 
potential role of epigenetic modification in disease manifestation of UC or postnatal 
development. The finding might be helpful to support the combinational epigenetic and 
microbiota based therapies of intestine inflammation.   
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6.  Zusammenfassung 
Der Einfluss des Mikrobioms auf epigenetische Muster und Differenzierungsprozesse in 
Zellen der intestinalen Mukosa ist noch immer weitgehend unverstanden. Die vorliegende 
Studie unternimmt den Versuch, diesen Zusammenhang in verschiedenen Modellen 
näher zu beleuchten. Ich habe hierbei genomische Hochdurchsatzanalysen, in Mäusen 
und Menschen, verwendet, um parallel Transkriptom- und Epigenomsignaturen (DNA 
Methylierung) in der Mukosa als auch die phylogenetische Diversität des intestinalen 
Mikrobioms zu untersuchen. Im ersten Teil der Arbeit wird eine drei-stufige, 
epigenomweite Assoziationsstudie vorgestellt. In dieser Studie wurden intestinale 
Biopsien von zehn eineiigen Zwillingspaaren, welche diskordant für die 
Krankheitsausprägung Colitis ulcerosa (UC) sind, mittels moderner 
Sequenzierungsverfahren (16S rRNA Gensequenzierung) und Microarray (HM27 und 
Affeymetrix U133) analysiert. Die Ergebnisse aus dieser Studie wurden mit Hilfe einer 
unabhängigen Kohorte an UC-Patienten und gesunden Individuen (n = 20 in zwei 
Gruppen) validiert. Ein Schwerpunkt der Analyse lag hierbei auf der Gruppe der 
entzündungsregulierenden Gene. Es konnten weiterhin Beziehungen zwischen 
bestimmten bakteriellen Taxa und DNA-Methylierungsmuster des Wirts nachgewiesen 
werden. Die Befunde bilden eine interessante Grundlage, um den Zusammenhang von 
Mikrobiota als Umweltfaktor mit der Entstehung von chronisch entzündlichen 
Darmkrankheiten weiter funktionell zu charakterisieren. 
Der zweite Teil der Arbeit beschäftigte sich mit dem Einfluss von kommensalen Bakterien 
auf Differenzierungsprozesse intestinaler Epithelzellen in Mäusen. Hierbei wurden 
Darmepithelzellen (IECs) aus GF und CONV-R Mäusen in drei verschiedenen 
Entwicklungsstadien entnommen. Zur Messung der dynamischen Muster des 
Transkriptoms und des Methyloms wurden RNA-Seq und RRBS (reduced representation 
bisulfite sequencing) angewendet. Es wurde beobachtet, dass die DNA-Methylierung und 
Genexpression in IECs durch das postnatale Entwicklungsstadium beeinflusst wird. Dies 
deutet darauf hin, dass epigenetische Prozesse zur Weiterentwicklung beitragen und die 
zugrundeliegenden endogenen Programme weitestgehend unabhängig von mikrobiellen 
Einflüssen funktionieren. Die Daten zeigen aber auch, dass die Darmflora, im postnatalen 
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Entwicklungsverlauf, spezifische Teile der epithelialen Transkriptmuster beeinflussen 
kann. Dabei wird nur eine kleine Fraktion von mikrobiellen Reaktionsgenen, welche im 
Bereich des IEC Wachstums und der Immunantwort wirkt, durch deren DNA-Methylierung 
beeinflusst.  
Zusammenfassend bestätigen die gezeigten Ergebnisse, dass die Interaktion von Wirt 
und Mikroflora einen wichtigen Kontrollpunkt der intestinalen Entwicklung, aber auch von 
Entzündungsprozessen darstellt. Die Diskussion, ob die Interaktionen ein 
Krankheitssymptom oder eine Krankheitsursache darstellen, steht noch immer im Raum. 
Dennoch deuten die Ergebnisse auf eine potentielle Rolle der DNA Methylierung sowohl 
beim postnatalen Wachstum und funktionellen Differenzierung der Mukosa als auch bei 
der Entstehung von chronisch-entzündlichen Erkrankungen hin. Diese Ergebnisse 
könnten bei der Suche nach kombinierten, epigenetisch und mikrobiell basierten 
Therapien gegen Darmentzündungen hilfreich sein. 
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coach and sharing the funny story in the Room 4.20.  
To all the brothers and sisters in the church: for non-stop encouraging each other, either 
in prayer or in the divine supply from God’s word. This mutual and spiritual encouragement 
helps me not to forget the initial calling of God to be here. 
To my family, Dad, Mom, Brother, Aunts and all the other family members: for all the 
caring and understanding in my difficult moment, not to stress me but comfort me. 
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To My Dear Wife Ching-Ting: Being with me all the time especially in my last year of PhD. 
Holding my hands, standing together and growing up together in the grace of God. You 
are the best gift to me from God. 
Sorry for those who didn’t list above, I hope you also receive my appreciation for all your 
help in my research work.  
Last and the most important, to my dear Lord Jesus: Thanks for bringing me here in 
Germany, to be you testimony and part of the divine history. For remind me not to forget 
the responsibility as a Christian in the world.  
I want to quote some sentences from the book “The World Situation and God's Move” as 
my ending: (As a Christian) What is our responsibility? We must bear the testimony of 
Jesus…We must be witnesses to Him... We must bring forth fruit by abiding in Him …We 
live Him according to this view we have of Him. We live the all-inclusive, extensive Christ 
who is now the life-giving Spirit as the ultimate expression of the Triune God after many 
processes. And we meet together according to locality as the church, the church which is 
not only an assembly but also the Body, the new man, the lampstand, and the bride. We 
also practice the genuine oneness in every locality—one Body, one Spirit, one city, one 
church. Such a living is our ultimate responsibility213. 
21.04.2017 
Wei-Hung in Kiel  
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Chinese version 
「流淚灑種的，必歡呼收割」--詩篇一百二十六篇第五節 
2013年三月，在眼淚中揮別家人與故土，踏上了未知的旅程，在遙遠德意志的小城，吹
著熟悉又陌生的海風，開始了新的生活。不意外的，在四年多的殷勤工作後，即將在基爾
拿到我人生中最後一個學位。四年半的變化，一言難盡。從單身變已婚；從一句德文都不
會說，到現在能與路人隨意地聊兩句；從對生物資訊一無所知，到現在能看懂生物資料處
理的細節。我相信，過程中的每一滴眼淚，都是幫助我成長的養分。當然，一路走來並非
單獨，我接受過許多人的扶持與鼓勵，沒有你們，就沒有今天的這本論文。 
首先的感謝，給當初給我機會的 Philip Rosenstiel教授。謝謝您的許多耐心，包容我這個
生物領域的外行人，讓我在這邊的四年裡，能沒有壓力的做研究。您的專業想法還有處事
態度，都是我人生的導師。 
再來要感謝在這四年中指導我的許多 Postdoc: Ateeq, Rob, Felix and Maren. 在我們一起
合作的計畫中，給了我很多寶貴的建議和指教。在論文的撰寫與計畫的執行上，沒有你們
的幫忙，不可能有這麼順利的進展。 
除此之外，要謝謝 Priya 和 Pankaj，一起在 RTG三年多的時間，我們一起經歷許多有趣
的事。也謝謝你們在論文撰寫跟找工作的規劃上給我許多正面的影響。 
當然，IKMB對我來說，不只是工作的地點，更像是彼此關心的群體。要謝謝同一個辦公
室的每一位，在遇到挫折時一起的打氣與鼓勵，互相吐吐苦水。當工作疲累時，在紅沙發
上聊一聊有趣的事，再繼續往前。Richa, Anupam, Phili, Jacqueline, Frauke, Anna, 
Stefii, Antonia, Alejandro, Go, Daniela… 
還要謝謝在這幾年一起成長，教會的弟兄姊妹們，不論是 SKYPE的交通禱告，或是聚會
中的神聖供應。讓我在繁忙的工作中，不忘記當初神呼招我們來到此地的異象。 
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給我親愛的家人，謝謝爸爸媽媽，總是關心我，讓我在德國能夠無後顧之憂的打拼奮鬥。
弟弟，姑姑們，給我許多的支持。最重要的是我親愛的老婆靖婷，陪伴我最後一年的博士
生涯，有妳真好，我們在這裡一起努力，一起經過人生變動的階段，我們有主有召會。在
德國的生活，還要繼續互相扶持，去門徒化萬民直到這世代的終結。 
最真實的感謝，給我最愛的主耶穌。是神帶領我來到這裡，並且是他願意我們留下來。節
錄一段話從「世界局勢與主的行動」書中出來 ：(當一位基督徒) 我們的負擔是什麽？我
們的責任是什麽？…我們必須背負耶穌的見證，…我們必須是祂的見證人，…我們必須借
著住在祂裏面而結果子。…我們的責任乃是活基督，在我們日常的生活中為祂作活的見
證。…我們照著對祂所有的看見來活祂。我們活這位包羅萬有、延展無限的基督，祂現今
乃是賜生命的靈，作經過許多過程的三一神終極的彰顯。並且我們按著地方聚集一起成為
召會，不僅是會集，也是基督的身體、新人、燈台和新婦。我們在各地實行真正的一－一
個身體、一位靈、一個城市、一個召會。這樣的生活乃是我們終極的責任。 
21.04.2017 
暐弘于基爾港 
 
